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ABSTRACT
Due to the crucial antioxidant role of Thioredoxin (Trx) system in various vital
cellular processes; DNA synthesis, oxidative stress defense, protein folding, apoptosis
and cell growth, this fundamental system is widely expressed in mostly all life’s
kingdoms. Thus using metagenomic approaches to characterize novel Trx system in
unexplored harsh environment will open the window for understanding the evolution of
Trx system and its unique adaptation in extreme habitations. One of the unexplored
unique ecosystems is the Red Sea’s Atalntis II brine pool, specifically, the lower
convective layer (LCL). The exceptional harsh conditions of the LCL; anoxic condition,
high temperature around 70°C, high salinity (26%), and high metal content, have a
significant contribution for being a unique infrequent ecosystem.
The objective of this study is to characterize a novel Trx isolated from the LCL.
Successfully, in the experimental part, Trx was expressed in E. coli and purified, where
the purified Trx has shown a clear antioxidant activity with a unique
thermohalophilicity.
In conclusion, we have characterized a unique antioxidant Trx protein.
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Chapter 1: Literature Review
1.

Red Sea; The Unique Ecosystem
The Red Sea has different names in different languages; Al Baḥr Al Aḥmar in

Arabic, Mare Rubrum in Latin (which means Arabian Gulf or Sinus Arabicus), while in
the Greek language known as Erythra Thalassa. Interestingly, the Red Sea has got its
name from the changes in color observed in its waters. Typically, the Red Sea has an
intense blue-green color; however, it is inhabited by extensive blooms of sea sawdust
(Trichodesmium erythraeum algae) at the sea surface that upon dying off, turn the color
of the sea to a reddish brown color6. The Red Sea was formed about 5 million years ago
due to the split of the African and Arabian plates. It is located between the Asian and
African continent, where it is bordered by eight countries; Kingdom of Saudi Arabia,
Egypt, Sudan, Jordan, Yemen, Eritrea, Djibouti and Israel as shown in Figure 1.

Adopted from http://www.coral-reef-info.com/red-sea-coral-reefs

Figure 1: Map of the Red Sea
The Red Sea is located between the Asian and African continent, where it is bordered by eight
countries; Kingdom of Saudi Arabia, Egypt, Sudan, Jordan, Yemen, Eritrea, Djibouti and Israel.

1

Basically, the Red Sea is a narrow strip of water that extends from Egypt at the southeast
for about 2,000 km towards the Bab el-Mandeb Strait that joins with the Gulf of Aden
and thereafter with the Arabian Sea. From the geological point of view, the Red Sea
separates the coasts of Sudan, Egypt and Eritrea at the west, while the coasts of Saudi
Arabia and Yemen at the east 6 .

1.1

Red Sea Oceanography
The surface area of the Red Sea is about 440,000 km² with maximum

depth of 2.2 km and 2250 km long. The temperature at the surface of the Red
Sea is ranging from 28 °C to 34 °C, that’s why the Red Sea is considered as one
of the warmest seas worldwide. In addition, the Red Sea is characterized by its
high salinity, where it is one of the most saltiest water bodies worldwide

6.

Actually, there are three main reasons for being dense and of high salinity;
Firstly, the high evaporation rate (net evaporation rate 1.4 – 2 m yr

-1)

that is

coupled with the high temperature of the water’s surface. Secondly, absence of
substantial rivers that can drain into the Red Sea. Finally, the significant low
rainfall rate (about 2.36 inch annually).7

1.2

Deep Oceanic Basin
The Red Sea is characterized by having a deep oceanic basin. This deep

basin comprises about twenty five brine pools
occupy these brine pools. Brine pools

8,

where sequestered hot brines

can be defined as

large

isolated

depressions filled with water at the seafloor. The impression of a pool down at
the seafloor results from the high salinity of the hot brine existing there, leading
to a denser environment rather than the neighboring water, showing poor
capacity to blend together. And that is why brine pools could be known as
submarine lakes. 9
Basically, the environment at the Red Sea’s bottom is exceptionally unique and
harsh in terms of oxygen depletion, high salinity, enormously high temperature,
and heavy metal enrichment. However, there are significant differences between

2

the characteristics of the brine pools of the Red Sea. General speaking, the
hottest and saltiest brine pools are usually in deep nearby the seafloor

9.

Furthermore, it is believed that the high temperature of the brine pools of the
Red Sea is originated from the earth’s tectonic activity, where this activity tends
to create cracks and fractures at the seafloor sediment, and in turn the deep sea
water penetrates these fissures as shown in Figure 2.

As a result, the penetrated

water got heated by the effect of submarine magma and starts to absorb
minerals. Finally, the convective currents returns back the heated water to the
seabed surface, forming a distinguishing layer of brine, owing to its high
density. Stereotypically, the sediments of the brine pools are metal rich; sulfides
of iron, copper and zinc, in addition to high value metals as gold, cobalt and
silver. 9, 10

Adopted from http://krse.kaust.edu.sa/spring-2010/research.html

Figure 2: Tectonic Activity and formation of brine pools
(1) The confined tectonic activities (2) lead to the formation of fissures, which in turn
allows the penetration of deep-sea water forming brine pools. (3) The submarine magma
heats the deep sea water (4) and thus, allows the absorbance of minerals that returned
back to the seabed sediment by the action of convective currents 9,10.
3

2.

Atlantis II Deep brine pool
There are twenty five diverse brine pools existing at the bottom of the

Red Sea 8; Atlantis II Deep, Discovery Deep, Chain Deep, Valdivia Deep, Kebrit
and other brine pools. Each brine pool has its own characteristics in terms of
salinity, temperature and metal enrichment. In 1965, the first two hydrothermal
sites within the oceans to be discovered were the Atlantis II Deep and Discovery
Deep in the Red Sea, where they are located at 21°20‘N between 2000 and 2250
m depth, additionally, the surface area of Atlantis II Deep and Discovery Deep
are about 6 x 13 Km and 4 x 3 Km respectively 11 (Figure 3).

Adopted from http://krse.kaust.edu.sa/spring-2010/research.html

Figure 3: Atlantis II Deep and Discovery Deep brine pools in the Red
Sea
The Red Sea map is showing the location of the Atlantis II deep, which is the largest
brine pool in the Red Sea till current, and Discovery deep. Basically, both brine pools are
located at 21°20‘N between 2000 and 2250 m depth. The bottom color legend is showing
the depth of each brine pool in meters11.
4

During that time the recorded temperatures were 56°C for Atlantis II Deep and 45°C for
Discovery Deep brine pool

11.

Interestingly, from November 1966 to February 1969, the

measured temperatures for the uniform vertical layers of the Atlantis II brine pool have
showed an obvious increasing pattern, where the temperature of the lower convective
layer had increased by 2.7 °C, while the upper convective layer had increased by 5.6 °C
12.

Consequent measurements for the Atlantis II brine pool have demonstrated a

continuous increase in temperatures, where in 1997 have reached 67.1 °C and by October
2008 have reached almost 70 °C as per KAUST (King Abdullah University for Science
and Technology) Red Sea expedition in fall 2008.

9, 11

That is to say, the temperature of

the Atlantis II Deep has increased 14 °C within 43 years, with an approximate rate of 0.3
°C increment per year 11. Table 1 is showing temperatures and salinity for different layers
of Atlantis II Deep and Discovery Deep.

Table 1: Different parameters for Atlantis II and Discovery Deep brine pools
measured in 2008 11.

Atlantis II Deep
Temperature Salinity
(ᵒC)
(psu)
LCL
UCL1
UCL2
UCL3
UCL4

68.28
57.32
51.25
47.98
43.53

Discovery Deep

Interface Temperature
depth (m)
(ᵒC)

252
162
118
99
87

2048
2027
2013
2006
2002

44.99

Interface
depth (m)
2059

From the above table, it is clear that, by going down from the water surface to the seabed,
the layers of the Atlantis II brine pool are settled as follow: firstly, the upper convective
layer (UCL), which is composed of four layers; UCL1, UCL2, UCL3 and UCL4, where
UCL4 is at depth of 2002 m while UCL1 is at 2027 m. Secondly, the middle convective
layer and finally, the lower convective layer (LCL) at the maximum depth of 2,048 m.
Both temperature and salinity increase by going deeper across the layers of the Atlantis II
Deep to reach its maximum at the LCL, where temperature is about 68.28 ᵒC and salinity
252 practical salinity unit (psu). On the other hand, the Discovery Deep brine pool is at
depth of 2059 m, while its temperature is only 44.99 ᵒC 11

5

Practical speaking, Atlantis II brine pool is considered as the biggest brine pool
existing in the Red Sea, where its surface area is represented by about 60 km2.
The unique harsh circumstances of the Atlantis II Deep make this environment
amongst the most infrequent environments existing on Earth

7.

The Atlantis II

brine pool is located at the depth of 2,190 m and segmented into numerous
vertical convective layers. Both temperature and salinity increase by going
deeper across the layers of the Atlantis II Deep. By going down from the water
surface to the seabed, the layers of the Atlantis II brine pool are settled as
follow: firstly, the upper convective layer (UCL), which is composed of four
layers; UCL1, UCL2, UCL3 and UCL4, where UCL4 is at depth of 2002 m
while UCL1 is at 2027 m. Secondly, the middle convective layer and finally, the
lower convective layer (LCL) at the maximum depth of 2,190 m 11.

In our study, we are much interested in the lowest layer of the Atlantis II brine
pool. The environment of the LCL has unusual blend of tough conditions;
extremely high temperature that reaches 68.2°C, salinity of about 26%, which is
7.5 folds more than that of other seas and its pH value is 5.3

5, 10.

Furthermore,

the LCL of Atlantis II Deep is almost oxygen depleted environment (anoxic) and
highly enriched with sulfides of iron, zinc, copper and other heavy metals, in
addition to high value metals as silver, cobalt and gold

9, 10, 11.

That is why; it is

very attractive spot to understand the structural and functional modifications of
enzymes and proteins that have been adapted in sake of survival of the microbial
communities in these harsh abiotic conditions, in addition to the expectation to
discover novel genes, proteins and metabolic pathways that can be conveniently
applied in the industry of biotechnology or pharmaceuticals. In this study, we
have characterized TrxATII in the LCL.

6

3.

Thioredoxin System
Due to the crucial antioxidant role of thioredoxin system in various vital cellular

processes; DNA synthesis, oxidative stress defense, protein folding, apoptosis and cell
growth, this fundamental system is widely expressed in mostly all life’s kingdoms from
Archebacteria to higher eukaryotes 1. Basically, Thioredoxin system is comprised of three
main key players; thioredoxin protein (Trx), thioredoxin reductase enzyme (TrxR) and
Nicotinamide adenine dinucleotide phosphate co-enzyme (NADPH) as shown in Figure
4. In this antioxidant system, the role of TrxR is to reduce the oxidized inactive state of
Trx (comprising a di-sulphide (S-S) bridge) into the reduced active form (comprising
thiol (SH) groups) through migration of electrons from NADPH to Trx via TrxR. In turn,
the reduced active Trx can maintain the reduced states of different cellular proteins
against oxidative stress initiated by different molecules as nitric oxide and hydrogen
peroxide 2. Furthermore, Thioredoxin system is an essential source of hydrogen for
numerous reducing enzymes as sulphate reductase, ribonucleotide reductase and
sulphoxide reductase 3.

Adopted from Physiological functions of thioredoxin and thioredoxin reductase, S. J. Arner and
A. Holmgren, Eur. J. Biochem. 267, 6102-6109 (2000)

Figure 4: Thioredoxin system
The schematic figure illustrates the reduction of the disulfide inactive oxidized form of
thioredoxin (Trx-S2), to the active dithiol reduced form of thioredoxin (Trx-(SH) 2), by
the action of both thioredoxin reductase (TrxR) and NADPH. Subsequently, Trx-(SH)2
reduces other oxidized disulfides protein, yielding Trx-S2. Moreover, TrxR may have
other substrates rather than the homologous Trx to reduce.2, 3

7

3.1

Thioredoxin; The redox protein
Thioredoxin (Trx) is a small monomeric redox protein; about 12,000

Dalton. Trx protein is widely expressed among most species from Archebacteria
to eukaryotes and humans 1. The reason for being highly conserved among wide
variety of prokaryotes and eukaryotes is the association of Trx in numerous vital
cellular processes and functions, including and not limited to, DNA synthesis,
oxidative stress defense, protein folding, apoptosis and cell growth

13.

As a

redox protein, Trx reduce other intracellular and extracellular oxidized proteins
comprising disulfide bridge through the exchange of cysteine thiol-disulfide
bond, where the Trx itself get oxidized forming a disulphide (S-S) bridge as the
Cysteine residue oxidized to Cystine residue as shown in Figure 5. Further on,
the oxidized Trx get reduced again forming thiol (SH) groups by the action of
TrxR at the expense of a molecule of NADPH 13.

Adopted from http://www.cs.stedwards.edu/chem/Chemistry/CHEM43/CHEM43/Thioredox/FUNCTION.HTML

Figure 5: Disulfide Bridge Exchange
Thioredoxin (Trx) protein is characterized by having a catalytic active motif, which is
denoted by two vicinal Cysteines that comprise in-between two other amino acids;
Cysteine-Glycine-Proline-Cysteine (Cys-Gly-Pro-Cys). Upon reducing other oxidized
proteins, Trx get oxidized, where two Cysteine residues are oxidized to Cystine forming a
disulfide bridge through the exchange of cysteine thiol-disulfide bond. 14, 17

8

In 1968, the sequence of amino acids of Escherichia coli Trx1 was determined14.
Basically, on the level of amino acids, all thioredoxins are characterized by
having a Trx motif, where this redox active catalytic motif is denoted

by

having two vicinal Cysteines and comprise in-between two other amino acids;
Cysteine-Glycine-Proline-Cysteine

(Cys-Gly-Pro-Cys)14,15,16.

This

active

catalytic domain is located near the N-terminal side; C32 XX C35. The conserved
catalytic site CXXC used to undergo a reversible process of oxidation-reduction
via the two vicinal Cysteines

17.

In addition to the conserved Trx motif, there is

a number of amino acids that are highly conserved among the Trx sequence;
Aspartate 26, Alanine 29, Tryptophan 31, Aspartate 61 and Glycine 92 2 .
Despite of the various functions of thioredoxins (Trxs) - will be discussed in
details in the following sections - , all thioredoxins from prokaryotes to
eukaryotes display a high homology in sequence to the E.coli Trx 1, represented
by 27 to 69% identity, which is the well characterized protein15,

18.

Furthermore,

thioredoxins are showing the same global three dimensional structure, where
they comprised the same Trx fold. Basically, the Trx fold is composed of a
fundamental core of five β-strands that are flanked by four α-helices as shown in
Figure 6

19.

The Cys-Gly-Pro-Cys conserved domain is positioned on the

surface of the Trx protein, exactly at the terminal of the β-strand and at the start
of the long α-helix. Around the active catalytic site of Trx, there

is a

hydrophobic region, which has been proposed to be the central interaction site
for other oxidized proteins to be reduced

18, 19.

Using the Nuclear Magnetic

Resonance (NMR) spectroscopy, the Trx 3D structure for both forms of E.coli
Trx; reduced and oxidized have been determined

20.

The overall difference

between the two forms of Trx; reduced and oxidized remains elusive, where
there is a local conformational change within and round the active disulfide site,
in addition to more conformational states in

the reduced form of Trx, which is

reflected on the altered patterns of Hydrogen bonding18, 20.

9

Adopted from Martin, J. Thioredoxin - a fold for all reasons. Structure, 3, 245-250 (1995).

Figure 6: Thioredoxin Fold
The position of the helices in relevance to the central -sheet is demonstrated. The α l and α 3
helices (grey colored), are located behindhand the sheet in this orientation. On the other hand,
α 2 helix is located in front of the B-sheet. Moreover, the sites of insertions of other residues are
signposted by asterisks 19
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3.2

Thioredoxin System; Prokaryotes versus Mammalians
The mammalian cells are characterized by having a cytosolic thioredoxin

(Trx1),

cytosolic

thioredoxin

reductase

(TrxR),

mitochondrial

thioredoxin

(Trx2), mitochondrial thioredoxin reductase (TrxR2), membrane bounded Trx,
extracellularly Trx and extracellularly truncated Trx (Trx 80)

2

as shown in

Figure 7.

Truncated form of Trx

Modified from Arner, E. S. and Holmgren, A. Physiological functions of thioredoxin and thioredoxin
reductase. Eur. J. Biochem. 267, 6102–6109 (2000).

Figure 7: Mammalian Thioredoxin System
This Schematic diagram localizes the presence of thioredoxin (Trx) and thioredoxin
reductase (TrxR) within the mammalian various cellular compartments; nucleus,
cytoplasm, membrane bounded and extra-cellularly as follow 2:
1- Trx and TrxR within the cytoplasm.
2- Trx and its truncated form (Trx 80) are membrane bounded and extra-cellularly available
as well.
3- Mitochondria (Trx2 and TrxR2)

11

By comparing the Trx system in prokaryotes to high orders eukaryotes, the most
significant evolution is in the TrxR, which is a large selenocysteine-enzyme
(Figure 8) with a broader substrate specificity that shows an obvious variance
from those smaller TrxR existing in fungi and all bacteria, where the bacterial
TrxR has narrow substrate specificity as it only reduces the bacterial Trx 21

Adopted from Holmgren, A., Lu, J. Thioredoxin and thioredoxin reductase: Current research
with special reference to human disease. A. Biochem. & Biophys. Res. Comm. 396, 120–124
(2010).

Figure 8: Mammalian Thioredoxin System
The

mammalian

thioredoxin

redox

system

composed

of

thioredoxin

(Trx),

thioredoxin reductase (TrxR), and NADPH. The NADPH is the electron source
in the Trx system, which is mainly generated from the pentose phosphate
pathway. The oxidized (Trx-S2) is reduced by the TrxR (Seleno-enzyme) and
NADPH. Finally, the reduced (Trx-(SH)2) reduces the disulfide bond in various
proteins. Interestingly, under the oxidative stress conditions, the thioredoxin
secreted into the plasma, where it can be truncated (Trx80) 21
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3.3

Redox mechanism of Thioredoxin
The Cysteine residue at the redox active site located at the N-terminal,

where it is characterized by having a low pKa value, that is to say, it will act as
the attacking nucleophile that will reduce the disulfides of other proteins.
Basically, the oxidoreductase mechanism of Trx comprises two intermediates; a
transitory disulfide intermediate as well as a fast thiol-disulfide exchange in a
hydrophobic environment

18.

It is a reversible reaction, where Trx either broken

or form disulfides based on the redox potential of the substrate. The Trx of E.
coli (Trx1) is characterized by having a low redox potential (-270 mV), which in
turn guarantees that the reduced form of Trx (Trx-(SH)2) is the main di-thiol
reducing agent at the cytosol

3.

Interestingly, there is a big superfamily of

proteins, which that comprise one or more domains of Trx. Those proteins with
the Trx fold are existing in all organisms, where they can be clustered in six
main classes;

Glutathione peroxidases,

Glutaredoxins,

Protein

oxidoreductase (DsbA)

disulfide
19, 22.

Thioredoxins,
isomerase

and

Glutathione transferases,
bacterial

disulfide

Actually, the sequence homology among these

classes is highly limited with almost no common activity, however, there is a
common

functional

similarity

among

the

following

four

classes:

Protein

disulfide isomerases, thioredoxins, DsbA and glutaredoxins, where all of them
are redox proteins with active catalytic redox motif; -Cys-X1-X2-Cys- (where
X1 and X2 are any non-Cysteine amino acids). Although, the glutathione
peroxidases and glutathione transferases classes are missing the active catalytic
redox motif, they have a specific interaction with glutathione. A recent addition
to the Trx superfamily is the coined PICOT (protein kinase C-interacting cousin
of thioredoxin) and the Nucleoredoxin. The coined PICOT which interacts with
protein kinase C
clear function

23

is a larger cytosolic Trx like protein, which has unknown

24, 25,

while the Nucleoredoxin is a nuclear Trx like protein

showing an oxido-reductase activity 26.
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3.4

Role of Thioredoxin system in different organisms
As being fundamental antioxidant protein expressed in most kingdoms of

life, Trx has been revealed in at least a dozen of different systems, which is
evidence to

its

usefulness

in

nature.

Basically, the

common

physiological

function of Trx in most organisms is the essential conserved role as a highcapacity hydrogen donor system for other reductive enzymes in a magnitude
faster than those for dithiothreitol (DTT) or glutathione (GSH)

3, 16,

with high

specified functions in phage T7 DNA replication and assembly of filamentous
phage of Escherichia coli phages. Moreover, the identified role for Trx as a thiol
redox controller in chloroplast photosynthesis has been also recognized recently
in redox regulation of transcription factors and enzymes. Additionally, it was
proven that Trx has vital defensive roles against apoptosis and inactivation or
aggregation of cytosolic proteins during oxidative stress 2.

The following examples will show the different roles of Trx among most
organisms of different life’s kingdom; Trx participates in the DNA synthesis by
3,

Trx keeps the

27, 28,

additionally, Trx

acting as a hydrogen donor for ribonucleotide reductase
intracellular protein disulfides in the reduced active forms

has a fundamental role in signaling pathways as well as defense against
oxidative stress as being an electron donor for the thioredoxin peroxidases and
peroxiredoxins that catalyze the reduction of Hydrogen peroxide

29.

More

detailed examples for the different roles of Trx in numerous organisms are
briefed in Table 2.
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Table 2: Role of thioredoxin in various organisms
Organisms

Thioredoxin Role

All Organisms

Reduction of protein disulfides

Thioredoxin plays a vital role in reducing
intracellular protein disulfides 14, 28

DNA synthesis

Thioredoxin is a high capacity hydrogen donor
for ribonucleotide reductase 3

Reduction of methionine sulfoxide

Thioredoxin is a major hydrogen donor for
methionine sulfoxide reductases 84, 85

Many Organisms

Comments

Thioredoxin reduce peroxiredoxins that catalyze
H2O2 reduction and thus inhibit oxidative stress
and apoptosis induction29, 35, 86

Prevent oxidative stress

Hydrogen donor for 3’phosphoadenylsulfate (PAPS)
reductase
Plays a vital role in filamentous phage
assembly

Assimilation of sulfur by sulfate to sulfite
reduction 87, 88

Subunit of T7 DNA polymerase

Required for processivity 90

Plant

Regulates the enzymatic photosynthesis
of chloroplast

Photosynthesis is regulated by light thru
ferredoxin 91

Mammalia

Pregnancy

Synthesis of thioredoxin from cytotrophoblasts
takes part in implantation and establishment of
pregnancy 92, 93, 94

Bacteria and Yeast
E. coli Phages
(M13, T7, f1)

Exclusively, thioredoxin is the merely host E.
coli protein required for the assembly
and export of phage 31, 89

Thioredoxin secreted from glial cells promotes
neuronal survival at ischemia reperfusion 95

CNS

Thioredoxin induction prevent hyperoxia at
birth96

Birth

Regulation of Apoptosis

Reduced thioredoxin makes a complex with
ASK1and thereby prevents the downstream
signaling for apoptosis 32

Redox regulation of transcription
factors

Thioredoxin either activates or inhibits different
transcription factors are either activated or
inhibited by Trx 97
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3.4.1 Thioredoxin role in E.coli Phages
An extra function of Trx is to act as a structural component of other
enzyme via complex formation. This is obviously recognized in T7 DNA
polymerase, where reduced Trx-(SH)2 binds with a highly affinity to the DNA
polymerase forming a complex
30.

(1 : 1) offering the enzyme a high processivity

Markedly, only the reduced Trx-(SH)2 binds while the oxidized Trx-S2 is

unable to bind despite being closely related in their 3D structures. A comparable
structural activity role is presumed for the Trx role in filamentous phage (M13,
T7 and f1) assembly, although active site mutants were as efficient as Trx in its
wild status, however, the last had to be reduced firstly by Trx reductase for
effective functioning in phage assembly

31,

and thus creating a significant

similar situation as the interaction with T7 DNA polymerase.

3.4.2 Thioredoxin role in mammals
In the same way, the mammalian reduced form of Trx-(SH)2, but not the
oxidized form of Trx-S2, forms an inhibitory complex with the apoptosis
pathway; Apoptosis Signaling Kinase 1 (ASK1)

32.

Basically, the mammalian

reduced Trx-(SH)2 offers a redox regulation on apoptosis, where apoptosis
inhibited under the reduced conditions of the intracellular Trx-(SH)2

,

that is to

say, at the oxidative stress conditions, where apoptosis is activated, the Trx is in
the oxidized status. Additionally, this situation meets with the perception of the
pivotal role of oxidative stress in inducing apoptosis.
Different transcription factors are regulated by the redox activity of Trx.
Subsequently, this offers Trx a dominant role in the thiol redox regulation of
critical cell functions by modulation of the expression of specific target genes as
illustrated in the schematic diagram (Figure 9).
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Reactive Oxygen Species (ROS)

Cytokines
Growth
Factors

Phosphoprotein
Phosphateses /
Protein kinases

Receptors

Transcription
Factors

Gene
Expression

Antioxidants (Thioredoxin, Glutathione, Glutaredoxin)

Growth

Cellular
Response

Differentiation
Apoptosis

Figure 9: Oxido-reductase regulation of cellular systems
This Schematic diagram is showing the possible redox levels of regulation and their
cellular response; growth, differentiation or apoptosis. The oxidoreductase activity is
controlled by thioredoxin, glutathione or glutaredoxin systems and. The balance between
oxidants and antioxidants control the functioning of proteins directly and regulate the
gene expression indirectly32.
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For instance, Trx is crucial for the oxidoreductase regulation of the transcription factor
NF-kB

33;

a transcription factor that regulates the expression of several inflammatory

genes. Additionally, Trx has a wide-ranging intracellular antioxidant action, where its upregulation defends against oxidative stress conditions 34. Another general function for Trx
in cell signaling is being an electron donor for the family of thioredoxin peroxiredoxins
and peroxidases, where there are six members at least in mammalian cells that reduce
oxidizing agents as Hydrogen peroxide

29.

Although both glutathione catalases and

peroxidases could reduce Hydrogen peroxide, it was verified that the human thioredoxin
peroxidases (human TPxII) when up regulated in cells, they have showed inhibitory
effect on apoptosis induction via reducing levels of Hydrogen peroxide. In this manner,
there is a thioredoxin regulatory step on apoptosis induction, which is upstream the
apoptosis regulator proteins of the Bcl-2 family 35. Until now, the mechanism of secretion
of Trx from mammalian cells is unknown, as it is not depending on a signal peptide

36.

Moreover, the secreted human Trx was found to up regulate the IL-2 receptor with a
demonstrated activity for the co-cytokine factor from the T-lymphocytes 37. Surprisingly,
it was recognized that this factor and human Trx are the same protein 38, and thereby it is
now obviously clear the multi-tasks of the extracellular human Trx. The secretion of Trx
under oxidative damage and inflammation conditions has been detected in both normal
and neoplastic cells

36, 39.

From the clinical point of view, plasma levels of Trx are

elevated in different cases of patients; rheumatoid arthritis
operations

41

40,

cardiopulmonary bypass

and in Human immunodeficiency infected cases (HIV/AIDS)

42.

Basically,

extracellular Trx has various pro-inflammatory effects via induction of the cytokines
release from both monocytes

43

and fibroblasts

40.

Additionally, one of the recent

observed activities of Trx, is being a chemotactic protein, that is to say, it induces the
migration of T-cells, monocytes and neutrophils with a comparable potency to the
chemokines e.g. IL-8

44.

Mutated residues at the Trx catalytic active motif, which is

normally denoted by having two vicinal Cysteines and comprise in-between two other
amino acids (Cys-XX-Cys) to Serines caused a loss in chemotactic activity, proposing an
obvious demand for the oxidoreductase activity. Furthermore, as being a chemotactic
protein, the concentration-dependent activity of Trx is a bell-shaped relationship similar
to other chemotactic agents, with a maximum plasma concentration of 25 ng per ml. The
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only difference between Trx and other chemokines in being G-protein-independent. Also
it was found that Trx might inhibit the action of other chemokines

44;

thus if Trx levels

are highly expressed in severe acute inflammations, this could inhibit the cell migration,
leading to the increase of infection severity. Besides, the truncated Trx (Trx80), which is
found at the surface of monocytes

45,

is highly identical to Eosinophilic Cytotoxicity

Enhancing Factor (ECEF), which augments the capability of eosinophils to kill the
Schistosoma mansoni larvae

46, 47.

To wrap up, it is obviously clear that the mammalian

Trx system is a key player that is highly associated with many human diseases as shown
in Figure 10.
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Adopted from Thioredoxin and thioredoxin reductase: Current research with special reference to human disease.
A. Holmgren, J. Lu. Biochemical and Biophysical Research Communications 396, 120–124 (2010).

Figure 10: Mammalian thioredoxin system and human diseases
The mammalian Trx system is a key player that is highly associated with many human
diseases; cancer, cardiovascular, diabetes, neurodegenerative diseases, virus infection,
rheumatoid arthritis and others.
20

3.4.3 Thioredoxin role in Plants
Interestingly, plants are characterized by having their unique Trx system,
where there is a linkage from light to reduction of other disulfide proteins
through various chloroplast Trxs and ferrodoxin

48.

Trxs are implemented in a

broad spectrum of crucial functions in plants; growth, flowering, photosynthesis
and germination as well as development of seeds. Furthermore, plants have
extraordinarily different types of Trxs, where they are composed of six well
recognized types: Trxs f, Trx m, Trx x, Trx y, Trx h, and Trx o. Basically, each
type is located in a different plant cell compartment, where they function in a
cascade of processes. For the first time, in 2010 it was discovered that Trx
proteins have the capability to move from one cell to another, representing an
unusual form of communication between cells in plants.49
Furthermore, in plants, the seed is considered as the only tissue with a specific
function for the Trx/NADH system. Actually, the wheat grain is rich in proteins
comprising

disulfide

bonds.

Glaidens

and

Glutaenin

are

the

main

storage

proteins that interact with the Trx redox protein, where these proteins become
more liable to proteolysis as a result of Trx reduction in addition to the redox
regulation of disulfide inhibitor proteins. Thus, one of the major roles of Trx in
plants, is being as an early signal in seed germination.50

4.

Metagenomic; The Window for Unexplored Organisms
Microorganisms are constantly capturing the scientists’ attention due to

the fact of being the predominant components of the earth’s biota, where they
occupy various ecosystems and communities; sea and fresh water, soil, air, etc...
with crucial functions, which make them in turn largely contribute to the
diversity of genetic material of life

51, 52.

Basically, the genomes of the

microorganisms were estimated to be double to triple the combined genomes of
animals and plants

53.

Additionally, microorganisms are key players with huge

influence on human and animals’ health, where the number of microbial cells
inhabiting the human body estimated to be about 100 trillion cells (10 folds the
human being cells)

54.

Thus, this huge number of microbes inhabiting different
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communities is capturing the interest of scientists to reveal their unexplored
diversity that could lead to understanding and utilizing new metabolic pathways
or novel proteins.

4.1

Metagenomics Approach
The classical way to study different microorganisms was based on the

traditional lab culture; solid or liquid media. However, this approach did not
succeed except for 1% of the microorganisms, which means losing 99% of them
as a result of lacking simulation and mimics of their original environments
Fortunately,

the

metagenomic

approaches

have

resolved

the

52, 55.

biased

representation of the microorganisms via the direct isolation of the metagenomes
from

their

environmental

samples

for

further

characterization

via

cloning

vectors, construction of metagenomic libraries and then sequencing of the
genome

52.

And based on that, the Metagenomics term refers to analyzing a

variety of genomes isolated from environmental sample. Metagenomics term has
different

alternatives;

environmental

genomics,

ecogenomics

and

community

genomics 52.
After isolation and processing of

the metagenome from

its

environmental

samples, three main pathways can be tracked; Firstly, Direct DNA sequencing,
where the isolated DNA is randomly sequenced yielding huge amounts of
sequences (about 400 bp read-length) to be subjected to computational analysis
to have deeper analysis for the genome of

an environmental community.

Secondly, 16sRNA phylogenetic analysis that could yield comparative genomics
studies and the taxonomical classification. And finally, the functional screening
for novel enzymes and proteins’ discovery, or sequence based screening to study
novel metabolic pathways and genes, where both screenings processed via
library construction (Figure 11) 55.
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Metagenomics
Envirnomental
Samples
Processing

Direct DNA
Sequencing

Library
Construction

16sRNA
Analysis

Functional Screening
Approach
Sequence Screening
Approach

Figure 11: Metagenomics Pathways
After extracting the whole genome directly from their environmental samples
and processing, we can proceed in one of the following pathways; Direct DNA
sequencing, 16sRNA phylogenetic analysis or library construction (Sequence or
Functional analysis) 56.

23

Basically, the functional screening is based on testing the clones of the
metagenomic library on selective media that are enriched with a specific
substrate, where target clones can grow. On the other hand, the sequence based
screening comprises designing primers for targeting genes of interest 55.
Historically, the first time for the term ‘Metagenomics’ to be introduced was in
1998 by Jo Handelsman and her colleagues, when they isolated
of

soil

microorganisms

Chromosomes (BACs)

56.

and

cloned

in

E.coli

via

the metagenome

Bacterial

Artificial

Furthermore, one of the classical phylogenetic studies

was done on environmental samples extracted from the Sargasso Sea, where the
whole genome was directly amplified for the entire 16 rRNA genes without
culturing that leaded to the identification of new group of bacteria; the SAR11
cluster

57.

However, the idea of direct cloning of DNA from environmental

samples without amplification by PCR was formerly proposed in 1985 by Pace,
but was applied in 1991, where environmental samples were collected from
marine

picoplankton

community

and

DNA

was

isolated

and

cloned

in

bacteriophage lambda 58.

4.2

Pyrosequencing technology
Pyrosequencing technology is one of the advancement that supported the

Metagenomics

approaches

in

exploring

the

microbial

diversity

of

any

community. It is one of the Next-Generation Sequencing (NGS) methods that
have been applied in different metagenomic studies (Schuster, Fitz-Gibbon,
Biddle, Brenchley & House, 2008; Roesch et al., 2007; Poinar et al., 2006;
Sogin et al., 2006).

Pyrosequencing was developed in 1996 by Pal Nyren and

Mostafa Ronaghi in Sweden. Basically, it is a DNA sequencing technique
(known also as sequencing by synthesis), where it differs from the traditional
Sanger method (Chain termination reaction by dideoxynucleotides), in that it
counts on the detection of the release of pyrophosphate during incorporation of
complementary nucleotides. The pyrosequencing technique tends to amplify the
small

subunit

(SSU)

rRNA

hypervariable

region.

In

conclusion,

there

are

various advantages for this method; Firstly, although the generated reads from

24

the

pyrosequencing

are

shorter

than

that

from

the

Chain

Termination

Sequencing (traditional Sanger sequencing), where the pyrosequencing reads are
about 400 bp in length, while the Sanger sequencing reads approximately 700 bp
per read, however the generated pyrosequencing reads are more intensified in
magnitude

for

better

coverage

and

representation.

Secondly,

pyrosequencing

technique is of lower cost and finally, it generates unbiased results toward the
predominant species in the community 53 .

4.2.1

Pyrosequencing protocol
The

pyrosequencing

technique

relies

on

synthesizing

of

the

complementary strand for a single helix of unknown DNA by integrating a
single base pair at a time and detecting it after each incorporation. The template
strand of DNA is immobile, while different solutions of the four possible
nucleotides (Adenine, Thymine, Cytosine or Guanine) are consecutively added
and then removed. Light is generated only when the complement nucleotide
solution

fits

the

first

single

unpaired

base

in

the

DNA

template.

The

identification of the sequence of the DNA template has been allowed by the
sequence

of

the

four

nucleotides

solutions

that

generate

chemiluminescent

signals. The pyrosequencing reaction comprises the following; a single stranded
DNA template incubated with a sequencing primer with DNA polymerase that
incorporates the proper, complementary deoxynucleoside triphosphates (dNTPs)
against

the

DNA

template.

Consequently,

the

nucleotides’

incorporation

generates pyrophosphate (PPi). Additionally, the reaction comprises Adenosine
triphosphate (ATP) sulfurylase enzyme that converts the released PPi to ATP in
an equal amount in the presence of Adenosine 5´ phosphosulfate (APS). The
generated

ATP

mediates

the

conversion

produces quantitatively visible light in

of

luciferin

to

oxyluciferin

that

presence of luciferase enzyme and

apyrase enzyme that degrades the unincorporated nucleotides. Finally, a camera
detects the generated light and the received pyrogram is analyzed 59 (Figure 12).
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Single Stranded DNA
template + Hybridized
sequencing primer + DNA
polymerase
Incorporation

dNTPs

PPi

Degradation of
unincorporated
dNTPs

Apyrase

ATP Sulfurylase
ATP + Luciferase

Luciferin

Light

Oxyluciferin

Pyrogram

Figure 12: Pyrosequencing technology
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4.3

Construction of Metagenomic Libraries
The main objective of constructing a metagenomic library is to facilitate

the access to the isolated metagenome from an environmental sample for
advanced
proteins.

screening
Some

for

target

safety measures

genes,
should

biocatalysts,
be

enzymes

followed during

or

any

novel

constructing

a

metagenomic library; ensure that the isolated metagenome is well representing
the community of the environmental sample so as

to avoid any biased

representation, the DNA should be intact and not sheared to avoid developing of
chimeric products among the smaller fragments of DNA, contamination should
be avoided, and finally, in order to prevent any interference with further
downstream processes as PCR, the metagenome should be clean and free from
inhibitors

52, 60.

To isolate the metagenome from the collected samples via cell

lysis, there are two main methods; chemical and physical. The physical method
comprises freezing and thawing for the samples several times, followed by
sonication, but these steps could cause DNA shearing. On the other hand, the
chemical methods that lysis the cells via using SDS is characterized by being
much gentler than the traditional physical methods. Thus, a mixed recipe of both
methods can be used as per the nature of the sample, where the metagenome was
isolated from 52.
The type of the vector that will be used in constructing the library will be
decided as per the objective of the study. For instance, if the aim of the study is
to characterize single genes, thus we can go for small insert library, where the
used cloning vectors are plasmids (inserts size less than 10 kb). On the contrary,
if the purpose of the study is to characterize the whole operons or genes’
clusters, we have to go for large insert library, where the used cloning vectors
could be BACs (insert size range 100-200 kb), or fosmids (insert size range 2540 kb) or cosmids (insert size 25-35 kb)

61.

Regarding the surrogate host, the

most convenient and well established used host is the E. coli for various
advantages; its ease of transformation, high transformation efficiency and its
exemplified genetics

61.

Moreover, for the same DNA amount, the number of
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the clones generated from the small insert library are much higher than that of
the large insert library (about 10 folds), which allows the efficient screening of
61.

In the

analysis,

where

all expressed genes, especially those of low levels of expression
following section, we will discuss the screening approaches.

4.3.1 Sequence based approach
Usually

this

approach

is

followed

for

phylogenetic

primers are designed as per the conserved regions or domains of the target
protein

or

gene.

PCR

is

then

performed

for

screening

the

library

and

consequently, the whole clone is sequenced to identify the whole gene sequence
52.

One of the privileges of the sequence based approach over the functional

based approach that it does not depend on the expression of the cloned gene in
its host (E. coli); while the functional based approach is depending on the gene
expression in the surrogate host 52.

4.3.2 Functional based approach
Fundamentally,

the

functional

screening

is

based

on

examining

the

clones of the metagenomic library on selective or indicator media that are
enriched with a specific substrate, where target clones can grow demonstrating a
color change or halo zones around target colonies

61.

The main advantage of the

functional screening over the sequence screening that it relies on the gene
functioning away from its sequence, which in turn open the window of
opportunities for discovering novel proteins; enzymes, biocatalysts, receptors or
membrane transporters,

that

might

share the

same

identified proteins but with other unique gene sequence
drawback

in

the

functional

screening

is

the

functions
62.

with

However, the main

mandatory heterologous

expression of the cloned gene in the surrogate host; which is mostly E. coli
61.

other

gene
4, 52,

Though E. coli is the classical surrogate host used in the functional based

screening, the risk of failure of heterologous gene expression is valid with high
percentage. An example of such failure was demonstrated in a metagenomic
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study on the metagenome of 32 prokaryotes, where only 40% of the genes were
heterologousely expressed in E. coli, while 60% of the genes were missed

61.

Besides, it could be possible that the percentage of the successful heterologous
gene expression to be varied and could be lessen than 40 % as per the nature of
the environment where the samples have been collected from, for instance, the
extreme environments in terms of temperature, salinity, heavy metals, lack of
nutrients, etc. By analyzing the reasons behind the failure of heterologous gene
expression in E.coli, we have to pay attention that the isolated metagenomes
from their complex communities are expected to have unusual and unique
regulatory factors that are mandatory for the appropriate transcription and
translation, while the E.coli could lack them. An example for codon usage in E.
coli is the start codon, which is AUG; the most common start codon (91%),
versus other codons that could be preferred as start codons in other organisms or
environments

4.

Other reasons that could account for weak or failure of

heterologous gene expression are: toxicity of some genes upon expression
towards the surrogate host or lack of the required chaperones for folding protein,
yielding misfolded proteins 52.

5.

Adaptation of Organisms in extreme environment
Various organisms are inhabiting extreme environments; halophiles, thermophiles,

acidophiles, alkalophiles, etc..., where they produce unique proteins of exceptional
properties and characteristics so as to accommodate with the surrounding environment 63.
In our study, the collected samples were from a thermohalophilic environment; LCL of
Atlantis II Deep brine pool in the Red Sea, thus it is expected that our retrieved
thioredoixn is of thermophilic and halophilic nature.

5.1

Thermophilic adaptation
Conferring

temperatures,

to

the

bacterial

optimal
proteins

functional

activity

can

categorized

be

at

a

wide
into

range
4

of

groups;

hyperthermophiles (active at more than 80 oC), thermophiles (active from 45 oC
to 80 oC), mesophiles (active from 15 oC to 45 oC) and finally psychrophiles that

29

are

active

from

5

oC

to

10

oC

64.

Basically,

the

first

two

groups;

hyperthermophilic and thermophilic, can withstand and properly function at
extremely harsh circumstances; high metal content, low nutrients, high salinity,
temperature, etc…

64.

The main features of the thermostable proteins are the

covalent bonds, extra hydrogen bonds, the rich hydrophobic core and the Van
der Waals interactions65, 66, 67.

5.1.1 Forces influencing protein’s stability towards Thermo-Halophilicity
There are a variety of forces and bonds that influence the stability of
proteins. Basically, there is a balance between those forces that maintain the
native structure of protein versus other forces that could oppose protein’s
stability

68.

The main contributing force for the protein’s stability is the covalent

bond, where common electrons can be shared by two molecules. Thioredoxin’s
active site (Cys-X-X-Cys) is characterized by having two vicinal cysteines,
where cysteine amino acid tends to perform disulfide bridge (S-S) upon reducing
other amino acids using its sulfhydryl group (SH). The performed disulfide
bridge is a strong covalent bond. Thus, the thioredoxin’s active site is playing a
crucial dual role; maintenance of thioredoxin structural folding as well as the
catalytic antioxidant activity of the protein

69, 70.

On the other hand, although

Van der Waals forces, electrostatic and hydrophobic interactions do not share
electrons among molecules and characterized by being much weaker than
covalent bond, they have a role in the conformational stability of the proteins

69,

70.

5.1.2 Role of Salt bridges in protein stabilization
The salt bridge bond is a type of electrostatic interaction, where it is
formed between ionized residues of opposite charges. That is to say, salt bridges
could be in favor of protein’s stability or not for two main reasons; firstly, the
performed salt bridge could be of attractive or repulsive nature. Secondly, to
perform

the

electrostatic

interaction,

re-organization

of

the

conformational

structure of protein is mandatory, which in turn could affect protein’s stability.
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Consequently,

salt

bridges

play

different

roles

in

proteins;

molecular

recognitions, key and lock feature at enzymatic binding sites or protein’s
stability

68.

The locations of salt bridges within the protein structure are variant;

(a) on protein surface, (b) fully buried within protein structure or (c) partially
buried (Figure 13). Additionally, salt bridges are pH dependent, thus, the
presence of salt bridges in proteins is highly influencing the thermo-halophilicity
nature of proteins. Finally, it is well established that thermo-halophilic proteins
are characterized by being highly thermo-halophilic stable due to their richness in
salt bridges within their structures 68.

Captured from Bosshard, H.R., D.N. Marti, and I. Jelesarov, Protein stabilization by salt bridges: concepts, experimental
approaches and clarification of some misunderstandings. J Mol Recognit, 17(1): 1-16 (2004)

Figure 13: Different locations of salt bridges within protein structure 68
The figure is showing the probable locations of salt bridges within a protein moiety, where
the heavy line is demonstrating a polypeptide chain, while the following points are:
(a) and (b) are representing salt bridges on the surface of protein.
(c) is demonstrating fully buried location in the depth of protein.
(d) is demonstrating partially buried location in the depth of protein
(e) Other charges affecting salt bridges.
(f) Complex salt bridge.
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5.2

Halophilic adaptations
Halophilic organisms can exceptionally tolerate harsh salinity conditions, where

they can grow in media comprising salts from 0.5 M till 5 M as per their classification;
halo-tolerant, moderate halophiles, borderline extreme halophiles and extreme halophiles
71.

Furthermore, halophiles can be defined as microorganisms that are optimally grow at

0.85 M NaCl, with tolerability until 1.7 M NaCl. Basically, the osmotic balance within
the halophilic microorganisms and the surrounding environment is maintained via one of
two main tactics; (a) Salt out tactic: where osmotic solutes of organic nature as ectoine,
L-proline and glycerol are accumulated inside the cytoplasm of halophiles, allowing the
cells to flux out salts, without interfering with the activity of cellular proteins. (b) Salt in
tactic: where high molar concentration of ions; Chloride and Potassium are accumulated
inside the cytoplasm of halophiles, allowing the cellular machinery to be adapted to high
concentrations of salts while being active and functioning 72, 73 .

6.

Thioredoxin Therapeutic Applications
Thioredoxin

is

a

small

monomeric

redox

protein

(12

KDa)

that

ubiquitously exists in human body. It is considered as one of the defensive
proteins, which is induced in response to numerous oxidative stress conditions.
Adding to its anti-oxidative activity via dithiol-disulfide exchange, thioredoxin
has

anti-inflammatory

and

anti-apoptotic

activities.

The

overexpression

of

thioredoxin in different animal models has been demonstrated to be a key player
in the inflammatory disorders and oxidative disorders as well. Interestingly,
administration

of

recombinant

thioredoxin

has

shown

anti-inflammatory

efficacy in severe acute lung diseases. Furthermore, thioredoxin has shown antichemotactic activities

for neutrophils

as well

as inhibitory actions

against

macrophage migration inhibitory factor (MIF). To sum up, administration of
recombinant thioredoxin could

have a wide range of potential therapeutic

applications in the medical field that should be examined in various animal
models 74.
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7.

Study Objectives and Experimental Plan
The main objective of this study was to identify a novel TrxATII from

the LCL of Atlantis II Deep brine pool in the Red Sea. The proper primers have
been designed as per the conserved domains of Trx and the full gene was
retrieved by performing PCR directly on the 1x metagenome of the LCL,
followed by gene sequencing.

The second objective was the TrxATII heterologous protein expression after
being cloned in the proper expression vector and transformed into the proper
surrogate

host

characterized

(E.coli
by

being

BL21,

(DE3)),

His-tagged

where
to

allow

the

expressed
the

protein

protein

was

purification.

Additionally, the induction phase of the TrxATII was done by using IPTG,
where the expressed TrxATII appeared at its proper size on the SDS-PAGE gel.

The third objective was the purification of TrxATII. The purification procedures
was done using Nickel affinity chromatography, where the His-tagged TrxATII
was bound to the Ni+ ions, and subsequently, eluted with the proper elution
buffer that comprises imidazole of high concentration.

The fourth objective was to assess the activity of the purified thioredoxin.
Basically, we have examined the TrxATII antioxidant activity via different
assays; Oxidative stress induction assay on HepG2 cell lines (MTT assay),
DTNB reduction assay and Insulin reduction assay.

The final objective was to characterize the thermal stability and halotolerance of
the purified thioredoxin. To achieve this goal, TrxATII was incubated for a
definite time intervals at various salt concentrations and temperatures, followed
by measuring the residual activity of the protein. Figure 14 is showing
schematic representation for the experimental plan.
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Figure 14: Schematic representation for the experimental plan
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Chapter 2: Materials and Methods
1.

LCL Samples

All samples that have been used along the study were collected during the
expedition of KAUST (King Abdullah University for Science and Technology) at the
Red Sea in spring 2010. Moreover, the site where the samples have been collected was
the lower convective layer of the Atlantis II deep brine pool; latitudes 21° 13’N and 21°
30’N and longitudes 37° 58’E and 38° 9’E 8. The total volume of the samples was about
100 liters. Subsequently, the samples were serially filtered via 3 µm, 0.8 µm and 0.1 µm
filters. The aim of the serial filtration is to fractionate the prokaryotic community.

2.

Amplification of LCL genome

The whole genome of the Lower Convective Layer (LCL) of the Atlantis II brine
pool of Red Sea was amplified by Mr. Amged Ouf using REPLI-g Mini Kit
(Cat.No.150023, QIAGEN). Basically, the REPLI-g Mini Kit generates a high yield of
DNA based on Multiple Displacement Amplification (MDA) technology, where the Phi
29 polymerase (high-fidelity enzyme) is used to amplify complex genome in combination
with a denaturation step of gentle alkaline condition to allow a uniform amplification of
genomic loci. The kit yields about 10 µg DNA per 50 µl reaction that remains stable in a
long term storage conditions. Interestingly, the easy set-up of the reaction and the
convenient handling time (about 15 minutes) makes the REPLI-g Mini Kit a reliable
method to use in amplifying whole genome in precious samples 75.

2.1

Whole genome amplification Concept

The Multiple Displacement Amplification (MDA) technology is also known as
isothermal genome amplification. The MDA technology is based on binding random
hexamers to denatured fragments of DNA. Using the high-fidelity enzyme Phi29
polymerase at constant temperature, the strand displacement synthesis occurs, where
multiple priming events take place on every displaced strand, which serves as a template
that allows the generation of high outcomes and consistent yield of amplified DNA as
shown in Figure 15.
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Captured from http://www.qiagen.com/products/catalog/sample-technologies/dna-sample technologies/genomicdna/repli-g-mini-kit#productdetails

Figure 15: Consistent DNA yields using REPLI-g Mini Kit
Different starting materials comprising genomic DNA have been amplified using REPLIg Mini Kit, where the yields are ranging from 8 to10 µg.
The high-fidelity enzyme Phi 29 is a DNA polymerase - phage derived enzyme -, with
proofreading activity (3'→5' prime exonuclease activity). The Phi29 polymerase is
characterized by higher fidelity than Thermus aquaticus (Taq) DNA polymerase (about
1000-fold) as shown in Figure 16. Additionally, the REPLI-g Mini Kit is supported by a
unique buffer system that prevents slippage or stopping of polymerase along
amplification procedure via resolving any secondary structures as hairpin loops 75.

Captured from http://www.qiagen.com/products/catalog/sample-technologies/dna-sample technologies/genomicdna/repli-g-mini-kit#productdetails

Figure 16: LCL genomic amplification by Phi29 polymerase
[A] Taq polymerase may stop synthesis or detach from the DNA template upon coming
across a secondary DNA structure, thus could yield inappropriate DNA amplification and
short fragments [B] Upon coming across a secondary DNA structure, the Phi29
polymerase displaces the structure as shown allowing high integrity for the amplified
genome.
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2.2 DNA Denaturation
To proceed in the enzymatic amplification of the LCL genome, gentle alkaline
incubation is maintained instead of ordinary harsh conditions; high temperatures
incubation or high alkaline incubation. Subsequently, the gentle alkaline incubation
allows the uniform denaturation of LCL genome with a minimal DNA fragmentation and
the final DNA yield is characterized by high integrity and maximized length of the
amplified fragments, which in turn allows the genomic loci and sequences to be
represented uniformly without negative results or false positive. The effect of heat
denaturation versus alkaline denaturation for genomic DNA in terms of Ct values
(threshold cycle) (Figure 17). Basically, the Ct value (threshold cycle) is a relative
measure in the PCR reaction for the concentration of target DNA. The Ct value increases
with a decreasing amount of template. Thus, the lower the Ct values the better
representation of loci 75.

Captured from http://www.qiagen.com/products/catalog/sample-technologies/dna-sample
technologies/genomic-dna/repli-g-mini-kit#productdetails

Figure 17: Heat effect versus alkaline denaturation effect on loci representation
10 ng of genomic DNA samples were denatured at 95°C versus gentle alkaline denaturation
by REPLI-g Kit. Later on, after amplification, the CT values (threshold cycle) for 2 loci were
calculated and compared between the 2 conditions. It is clear that the CT values of the
amplified loci by the REPLI-g Kit is much lower than that of heat denaturation method, which
indicates better representation for the locus with no loss of sequences at these loci.
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2.3

Amplification Procedures
The LCL genomic sample is lysed by the addition of the lysis buffer, which has a

dual role; Sample lysis and DNA denaturation via its one minute gentle alkaline
incubation. Consequently, the denaturation step is stopped by
buffer, followed by addition of the

adding the neutralizing

master mix (including REPLI-g Mini DNA

Polymerase), where the multiple displacement amplification reaction proceeds at 30°C
overnight (at least 10-15 hours). The procedure of DNA amplification is illustrated in
Figure 18. Finally, the whole amplified genome can be stored –20°C for a long-term
period stable and consistent 75.

1

2

3

Captured from http://www.qiagen.com/products/catalog/sample-technologies/dna-sample technologies/genomicdna/repli-g-mini-kit#productdetails

Figure 18: Procedure of the whole genome amplification of the LCL
genome by REPLI-g Mini kit
Amplification of the LCL genome comprises 3 main steps:
110 ng of purified LCL genome undergoes gentle alkaline denaturation.
2Sample neutralization.
3Incubation at 30°C with REPLI-g master mix.
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3.

Retrieving TrxATII gene

3.1

DNA isolation
TrxATII gene was retrieved directly from the metagenome of the lower convective

layer of the Atlantis II deep brine pool (1x LCL) via PCR reaction. As per the conserved
regions of thioredoxin gene, we have designed the primers to retrieve the full gene as
follow; forward primer (TrxF) 5’- GGA TCC GTG CAA TCT GAA AGT CGA GAG
TC-3’ and the reverse primer (TrxR) 5’- AAG CTT TTA TCC ATG AGT GCG TGG
ACT AA -3’. Furthermore, the PCR conditions were as follow: initial denaturation at
95oC for 5 minutes, 35 cycles (95oC for 30 seconds, 63oC for 30 seconds and 72oC for 1
minute) and a final elongation stage at 72oC for 7 minutes. The used thermo-stable DNA
polymerase was DreamTaq DNA Polymerase (# EP0701, Thermo SCIENTIFIC).
Additionally, the used PCR thermal cycler was Veriti 96 wells (Model No.9902, Applied
Biosystems).

3.2

Agarose Gel Electrophoresis
Agarose gel electrophoresis is a well-known method in molecular biology, which

is used to separate a mixed population of DNA in the agarose matrix. By applying
electric field, the negatively charged biomolecules are separated based on their size
through the agarose matrix, where the small sized DNA fragments migrated faster
downwards the agarose gel

76.

We have used; 0.8% agarose, the running buffer was 1x

TBE (Tris/Borate/EDTA) for its good conductivity and less heat productivity, reference
molecular weight ladder; Thermo Scientific GeneRuler 1 kb Plus DNA Ladder 75 to
20,000 bp (Ferementas Cat. No.SM1331). We have run the 0.8% agarose gel in Bio Rad
electrophoresis chamber (Mini Sub® Cell GT) and finally the separated bands of DNA
fragments was viewed using Image Quant 300 (Serial No. 300-06-00130, General
Electric).

3.3

Excision and Extraction of TrxATII gene from agarose gel
At the proper size of TrxATII gene (~540 bp), we have excised the DNA fragment

from the 0.8% agarose gel with a clean, sharp scalpel. Consequently, to extract and purify
the DNA fragment, we have used QIAquick Gel Extraction Kit (Cat. No. 28704) supplied
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by Qiagen, where we have followed its protocol. Finally, we have the purified DNA
fragment in a 30 μl Buffer (10 mM Tris Cl, pH 8.5).

4.

Recombinant TrxATII Clones

4.1

Cloning and Transformation of TrxATII gene
TrxATII gene was then cloned into a high copy number vector. The used plasmid

was pGEM®-T Easy (Cat. No. A1360, Promega). Basically, pGEM®-T Easy is a
linearized vector with T-overhangs at the insertion site that significantly improve the
efficiency of ligation of PCR product with a compatible overhanging. Furthermore,
ligation procedure was done according to the manufacturer’s instructions. Subsequently,
2 ul of the ligation reaction was used to transform electrocompetent E. coli TOP10 cells
using MicroPulser™ Electroporation Apparatus (Bio-Rad) as per the instructions of
manufacturer. The tube containing transformed E. coli TOP10 cells and ligation reaction
was incubated with 950μl room-temperature LB broth / Ampicillin (100μg/ml) for 1.5
hours at 37°C with shaking (200 rpm). Finally, 100μl of each transformation culture were
plated on LB, Ampicillin (100μg/ml), IPTG (0.5mM) and X-Gal (80μg/ml) agar plates
and incubated overnight at 37°C. The features of the pGEM®-T Easy vector are shown in
Figure 19.

Figure 19: pGEM®-T Vector Map
Captured from the manual of pGEM®-T and pGEM®-T Easy Vector Systems
(Part#TM 042, www.promega.com)
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4.2

Screening of Recombinant Transformants
The pGEM®-T Easy vector comprises a multi-cloning site within the alpha

peptide coding sequence of β-galactosidase enzyme and flanked by T7 and SP6 RNA
polymerase promoters. Successful cloning of TrxATII gene into the pGEM®-T Easy
vector will interrupt the coding sequence of β-galactosidase enzyme and thus, successful
recombinant clones can be recognized by screening of colored colonies on indicator
plates (Blue/White screening of recombinants). The white colonies will comprise TrxATII
insert at the proper cloning region, while the blue colonies might comprise the TrxATII
gene but cloned in-frame with the lacZ gene or might not comprise the insert at all.
Twenty white colonies were picked up from indicator plates for gene sequencing.

5.

TrxATII gene Sequencing

5.1

Plasmid Extraction
To proceed in gene sequencing, firstly we need to extract the pGEM®-T Easy

plasmid comprising the TrxATII gene insert from the recombinant E. coli TOP10 cells
(White colonies). Out of the indicator plates, twenty white colonies were picked up with
autoclaved picks, where each picked colony sub-cultured in a separate falcon tube
containing LB broth/Ampicillin (100μg/ml) overnight at 37°C with shaking (200 rpm).
For plasmid extraction, we have used the PureYield™ Plasmid Miniprep System
(Cat.No.A1223, Promega), which is designed to extract highly pure plasmid DNA. We
have followed the manufacturer’s protocol in isolating the twenty plasmids. Finally, we
have 30 μl of each plasmid in a separate eppendorf tube and stored at -20°C, where the
plasmids stored in 10mM Tris-HCl (pH 8.5) and 0.1mM EDTA buffer. To determine the
concentration of the extracted plasmids, we ran them on 0.8% agarose gel
electrophoresis.

5.2

Chain Termination Sequencing
To carry out Sanger sequencing (Chain Termination Sequencing), Mr. Amged ouf

has used Applied Biosystems 3730xl DNA Analyzer machine using the BigDye®
Terminator v3.1 Cycle Sequencing Kit. For each plasmid, two reactions were performed,
where each reaction contains: Big dye terminator, 5X Sequencing Buffer, primer
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(forward or reverse), DNA template and the volume was completed using water. The
used primers were thioredoxin forward (TrxF) and thioredoxin reverse (TrxR).
Thermocycler conditions were initial denaturation step at 96oC for 1 minute, 25 cycles
(denaturation at 96oC for 10 seconds, annealing at 63oC for 5 seconds and extension at
60oC for 4 minutes). TrxATII gene sample to be sequenced was purified using the EdgeBiosystem Columns, dried and loaded into the 96 well optical plate.

6.

Computational Analysis

6.1

TrxATII sequence and alignment analysis
After sequencing the positive TrxATII clones by Applied Biosystems 3730xl

DNA Analyzer machine, the generated sequence was BLASTed against non-redundant
(nr) protein databases using Basic Local Alignment Search Tool (BLASTP) provided by
the National Center for Biotechnology Information (NCBI). Furthermore, the generated
sequence was aligned against the first hit; Trx Prochlorococcus marinus (accession
number WP_002807427.1), using ClustalW version 2.1

77,78

. Moreover, a multiple

alignment was generated for the TrxATII against other members of the Trx super family
using ClustalW version 2.1 to detect the conserved active catalytic site.

6.2

3D modeling of TrxATII versus Trx of Prochlorococcus marinus
Using the PyMOL Molecular Graphics System (Version 1.3 Schrödinger, LLC),

we have made a 3D modeling for the TrxATII versus Trx of Prochlorococcus marinus.

6.3

Construction of Phylogenetic tree
A Phylogenetic tree for the TrxATII was constructed using CLUSTALW version

2.1

77,78

. The generated tree is Neighbour-joining tree including the sequences most

similar to the TrxATII sequence.

42

7.

Expression of TrxATII

7.1

Cloning of TrxATII gene in Expression Vector
TrxATII gene was cloned into a high level expression vector with a TA cloning

site for efficient cloning. The used expression system was the Champion™ pET SUMO
Protein Expression System (Catalog No.K300-01) supplied by invitrogen™. Basically,
the Champion™ pET SUMO Protein Expression System utilizes a small ubiquitin-like
modifier (SUMO; Smt3 protein of the Saccharomyces cerevisiae) that facilitates
expression, purification, and generation of native heterologous proteins in the surrogate
host; E. coli. Additionally, the pET SUMO vector takes the privilege of the bacteriophage
T7 RNA polymerase that allows high-level, IPTG-inducible expression of heterologous
genes in E. coli under the T7 lac promoter, plus solubility enhancement of partially
insoluble proteins. Moreover, the presence of the N-terminal polyhistidine (6xHis) tag in
the pET SUMO expression vector allows purification of the recombinant TrxATII protein
against metal-chelating resin (Ni-NTA agarose resin, Cat.No. R901-15, Invitrogen™),
where the Ni-NTA resin has high affinity and selectivity for 6xHis-tagged recombinant
fusion proteins. The features of the pET SUMO vector are shown in Figure 20.
Following the manufacturer’s protocol, we have cloned TrxATII gene in pET SUMO
vector after performing PCR with the previously mentioned conditions. The ligation
reaction was incubated at room temperature for 30 minutes then stored at -20°C.

Figure 20: pET SUMO® Vector Map
Captured from the manual of pET SUMO Vector (Cat.No.300-01, invitrogen™)
43

7.2

Transformation of Expression Vector into E. coli
The BL21 (DE3) E. coli strain (supplied by invitrogen™) is precisely designed

for expression of heterologous genes under the T7 promoter. Following the
manufacturer’s transformation instructions, 2 ul of the ligation reaction was used to
transform the chemically competent BL21 (DE3) E. coli cells. After that, the tube
containing transformed E. coli cells and ligation reaction was incubated with 250 μl
room-temperature LB broth/kanamycin (50 μg/ml) for 1.5 hours at 37°C with shaking
(200 rpm). Finally, 100μl of each transformation culture were streaked on LB and
kanamycin (50 μg/ml) agar plates to be incubated overnight at 37°C.

7.3

Analyzing Transformants
To analyze transformants, we performed PCR reaction as the previously

mentioned conditions for each transformation culture using the TrxF (Thioredoxin
forward primer) and TrxR (Thioredoxin reverse primer). The generated PCR product was
run on 0.8% agarose gel electrophoresis to confirm the positive transformants.

7.4

IPTG-inducible Expression of TrxATII
Transformant BL21(DE3) E. coli cells comprising the pET SUMO vector with

TrxATII gene insert were sub-cultured in LB broth / kanamycin (50 μg/ml) with shaking
(200 rpm) and incubated overnight at 37°C. In the following day, in a clean autoclaved
500 ml. flask, 1 ml. of the overnight culture were added to 100 ml. of LB
broth/kanamycin (50 μg/ml) and incubated at 37°C with 200 rpm shaking for about 3
hours until reaching optical density (OD) from 0.4 to 0.6 at wavelength (ʎ) 600 nm,
where we measured OD using Ultrospec 3100 pro (UV/visible spectrophotometer,
Amersham Biosciences). After reaching the desired optical density, we started the
induction phase using IPTG (isopropyl β-D-thiogalactoside) of final concentration 0.1
mM, followed by incubation at 37°C with shaking at 200 rpm overnight.

By the

following day, we have isolated the E. coli cell pellets from supernatant via
centrifugation for 10 minutes at 5000 rpm using Allegra® X-12R centrifuge
(BECKMAN COULTER, USA). Moreover, the E. coli cell pellets were collected and
dissolved in 1ml. of the binding buffer (250 mM NaH2PO4 / 2.5 M NaCl) that will be

used later on in the purification of the expressed TrxATII protein. To extract the cell’s
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proteins out of the cell pellets, we applied 100 watts of sonication power for effective
processing using Branson Sonifier 150 machine (Model No.S-150D, USA), where we
freezed and thawed the cell pellets for three successive times in -80°C and 42°C
respectively and finally we applied sonication for 5 minutes (15 seconds on and 15
seconds off). To collect the total expressed proteins, we centrifuged the sonicated cell
pellets at 13,000 rpm for 10 minutes, where we separated the supernatant comprising the
whole cell’s proteins.

7.5

SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE)
SDS-PAGE is a well-known molecular biology technique that used to separate

proteins from a pool of different proteins based on their molecular weight through the
polyacrylamide sieve like matrix. The small sized proteins run faster than larger sized
proteins, where each protein represented by a clear separate band. In this technique,
proteins reacted with SDS (Sodium dodecylsulfate) forming negative charge complexes,
where the amount of SDS that bounds to each protein is approximately proportional to its
size

79.

We have analyzed the E. coli proteins on 17% SDS gel. To prepare the 17%

resolving gel, we have mixed; 3.75 ml 30% Acrylamide/Bisacrylamide (37.5:1), 3 ml
Tris-HCl (pH 8.6), 40 ul 20% SDS and 1.2 ml water, then just before casting the gel, we
added 48 ul 10% Ammonium per Sulfate (APS) and 12 ul of Tetramethylethylenediamine
(TEMED). To prepare the stacking gel, we have mixed 820 ul of 30%
Acrylamide/Bisacrylamide (37.5:1), 0.5 ml Tris-HCl (pH 6.9), 20 ul 20% SDS and 2.7 ml
water, then just before casting the gel, we added 20 ul 10% Ammonium per Sulfate
(APS) and 10 ul of Tetramethylethylenediamine (TEMED). The loading dye recipe was
1% SDS, 10% glycerol, 10 mM Tris-Cl (pH 6.8), 1 mM ethylene diamine tetraacetic acid
(EDTA) and 0.05 mgl/ml bromophenol blue. Then, for every 950 ul loading dye, we
added 50 ul of 2-mercaptoethanol as a reducing agent. To load the protein samples, we
added 6 ul of cell’s proteins to 24 ul of loading dye and allow denaturation at 90°C with
vigorous shaking for 5 minutes and finally, we loaded 20 ul of denatured protein per SDS
gel’s well. Furthermore, different samples were collected before and after induction.
The used electrophoresis apparatus was Bio-Rad Mini-PROTEAN Tetra Cell, where we
ran the cell’s proteins till before the end of the gel. For gel staining viewing the protein’s
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band, we used Commassie Brilliant R-250. The used reference molecular weight ladder
was ProSieve®Color Protein Markers (Cat. No.50550, Lonza).

8.

Purification of TrxATII
The pET SUMO expression vector is characterized by having N-terminal

polyhistidine (6xHis) tag that allows purification of recombinant TrxATII against metalchelating resin (Ni-NTA agarose resin, Cat.No.R901-15, Invitrogen™), where the NiNTA resin has high affinity and selectivity for 6xHis-tagged recombinant fused proteins.
Following the instructions of the manufacturer, we purified the E. coli whole proteins
under the native conditions, where we loaded the whole proteins on Ni-NTA agarose
resin after column’s equilibration with binding buffer (250 mM NaH2PO4 / 2.5 M NaCl)

for 3 successive times. Then, the column was gently agitated for 60 minutes to keep
the loaded proteins suspended within the resin to allow efficient binding. After resin
settlement by gravity, the resin washed with 8 ml native wash buffer (20 mM
imidazole/250 mM NaH2PO4 / 2.5 M NaCl) for 3 successive times to allow elution of

whole E. coli proteins except TrxATII protein that fused to polyhistidine (6xHis) tag.
Finally, TrxATII protein was eluted into 0.5 ml fractions using native elution buffer
(250 mM imidazole/250 mM NaH2PO4 / 2.5 M NaCl), via competition against

imidazole. Samples of purified TrxATII were taken for SDS-PAGE electrophoresis
analysis.

9.

Dialysis of TrxATII Fractions
The presence of imidazole within the eluted fractions of TrxATII might affect the

protein’s activity, thus we removed the imidazole via dialysis. We collected all eluted
TrxATII fraction in a dialysis bag, then we allowed imidazole exchange against 1x PBS
(Phosphate Buffered Saline) via gentle vortex at +4°C overnight. For preparing 10x PBS,
we mixed 80 gm NaCl, 2 gm KCl, 14.4 gm Na2HPO4 and 2.4 gm KH2 PO4 in 1 liter
autoclaved water (pH 7.4).
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10.

Quantification of TrxATII Fractions
After dialysis, we quantified the amount of TrxATII protein using the Thermo

Scientific Pierce BCA Protein Assay (Cat.No.23225, Thermo SCIENTIFIC). Basically,
this assay combines the reduction of Cu+2 to Cu+1 by protein in a basic medium with the
highly sensitive and selective colorimetric detection of the cuprous cation (Cu+1) using a
reagent comprising bicinchoninic acid (BCA). Accordingly, a purple-colored product is
formed as a result of chelation of two molecules of BCA with one cuprous ion.
Interestingly, this purple-colored product exhibits a significant absorbance at 540-590 nm
that shows a liner relationship by increasing the protein concentration over a working
range from 20μg/ml to 2000μg/ml. Moreover, we followed the manufacturer’s protocol to
determine unknown concentrations of TrxATII. The used reference protein standard was
bovine serum albumin (BSA). Finally, we plotted a standard curve.

11.

Redox Activity and Characterization of TrxATII

11.1

Insulin reduction activity assay

Thioredoxins are antioxidant proteins that assist the reduction of other proteins
via the exchange of cysteine thiol disulfide. Thus, the standard way to assess the redox
activity of Trx protein is the reduction assays. Basically, the insulin molecule consists of
two polypeptide chains; A and B chains, where they are linked together via disulfide
bridge 80 as shown in Figure 21.

http://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?id=7043&type=display

Figure 21: Structure of Human Insulin
Human insulin is composed of two subunit chains A and B. Chain A comprises 21 amino
acids, while chain B comprises 30 amino acids. The two chains are bounded by two
sulphide bridges enclosed in red circles. Upon reduction, the two chains separated
forming thiol groups (SH SH) and insulin aggregates formed, which can be measured
spectrophotomerically at 650 nm 78.
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The insulin reduction assay is based on the reduction of insulin chain, where its disulfide
bridge broken down (S-S to SH SH) in the presence of the active reduced form of
thioredoxin that results in the formation of insulin aggregates, which can be measured
spectrophotomerically at 650 nm. Moreover, the reduction initiation occurred in the
presence of Dithiothreitol (DTT). We have performed the assay in 1 ml reaction as
follow; In a clean cuvette, 2mM Ethylenediaminetetraacetic acid (EDTA), 100mM
KH2PO4, 0.7mg/ml insulin (Human insulin, Cat.No.I0908, Sigma, Denmark), 4μM
TrxATII, 0.33mM Dithiothreitol (DTT), and completed the final volume with water to 1
ml.

11.1.1 Thermo-stability
The redox activity of the TrxATII examined in the insulin reduction assay was
assayed after incubation of TrxATII at different temperatures (25-80oC).

11.1.2 Halophilicity
The redox activity of the TrxATII examined in the insulin reduction assay was
assayed at different NaCl concentrations (0-4 M).

11.2 In Vitro assay of TrxATII antioxidant activity
11.2.1 Cell Culture
Another way to examine the antioxidant activity of thioredoxin protein was to
induce oxidative stress conditions on mammalian cell line and then asses the role of
thioredoxin as an antioxidant. In this assay, we induced oxidative stress conditions on
HepG2; hepatic cancer cell line, where we obtained the cell line from the Holding
Company for Biological Products & Vaccines (VACSERA) in Egypt. To allow the growth
of HepG2 cancer cell line, we have used RPMI 1640 medium (Roswell Park Memorial
Institute) with L-Glutamine and 25 mM Hepes (Cat.No.BE12-115F, Lonza, USA)
containing 10% Fetal Bovine Serum (FBS) (Cat.No.DE14-701F, Lonza, USA) and 5%
penicillin-streptomycin mixture (10,000 units Potassium Penicillin and 10,000 μg
Streptomycin Sulfate per ml) (Cat.No.17-602E, Lonza, USA), where the cell line was
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incubated at 37 °C in a humidified atmosphere of 95% air and 5% CO2. The HepG2 cell
line reached a confluence stage after 24 hours incubation. Moreover, along the study, we
performed 15 passaging (from 35 to 50). To allow the growth of the cell line, passaging
was done from T-25 culture flask (25 cm2) to T-75 culture flask (75 cm2), where we used
to wash the cells gently with sterile 1x Phosphate Buffered Saline (PBS) and then allow
trypsinization using trypsin-EDTA (Cat.No.CC-5012, Lonza, USA).
In the seeding phase of the cells, we counted the viable cells via the trypan blue staining,
where 10μl of trypan blue was mixed with 10μl of cells and finally we used the
haemocytometer to count the viable cells. Furthermore, we seeded the cells in 96 wells
micro-plate, polystyrene, flat bottom, clear and sterile (Greiner, Cat.No.EK 25161),
where the cell count was fixed along the experiments to be about 20 X 103 per well. To
allow the seeded cells to attach and form confluent sheath, they were incubated at 37 °C
in a humidified atmosphere of 95% air and 5% CO2 for 24 hours before examining the
antioxidant activity of TrxATII protein or inducing oxidative stress by different
concentrations of Hydrogen peroxide (H2O2) on HepG2 cell line.

11.2.2 MTT Cytotoxicity Assay
The MTT assay is a well-known colorimetric assay, which is used in assessing the
viability of cells. This assay is depending on the cellular oxido-reductase enzymes in the
mitochondrial cells, where they could be an indicator for the existing viable cells.
Basically, the oxido-reductase enzymes are having the ability to reduce the MTT dye [ 3(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] to the formazan, which is
insoluble purple color. The MTT dye characterized by being sensitive to light that is why
it should be stored in dark place and the assay should be carried out in dark conditions as
well

81.

Thus, to assess the antioxidant role of TrxATII protein, we induced oxidative

stress conditions on the HepG2 cancer cell line in presence of thioredoxin and
subsequently, we determined the cell viability using the colorimetric MTT assay.
Basically, we examined different concentrations of TrxATII (1, 2.5, 5, 10 and 15 μM),
where each concentration was incubated with the fully attached HepG2 cells for 1 hour
and then exposed to oxidative stress via different concentrations of H2O2 (100, 200, 800
and 1600 μM) for further 4 hours. Our control in this experiment was HepG2 cells
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incubated only with nourishing medium (RPMI 1640, Lonza, USA). The final volume
that was used in the 96 wells micro-plate for any condition; TrxATII, H2O2 or nourishing
RPMI media was fixed to be 100 μl per each well. After incubating the seeded HepG2
cells with different concentrations of thioredoxin for 1 hour followed by incubation with
different concentrations of H2O2 for further 4 hours, the old media were removed from all
the 96 wells and replaced by 100 μl RPMI 1640 medium and 20 μl MTT dye
(Cat.No.20395.01 Serva, Germany) per each well. After that, the 96 wells micro-plate is
incubated in dark at 37 °C in a humidified atmosphere of 95% air and 5% CO2 for 3
hours. Consequently, the RPMI 1640 medium containing MTT dye removed from all 96
wells and replaced by 100 μl DMSO (5mg/ml) to solubilize the purple color precipitate
(formazan). Using the FLUOstar OPTIMA microplate reader (BMG LabTech, Germany),
the absorbance of formazan was measured at 590 nm. For further confirmation, each
examined concentration of TrxATII and H2O2 was done in triplicates and the whole set of
experiment was done 3 times in 3 different days. Furthermore, to calculate the percentage
of viable cells, the absorbance of each sample was divided by the absorbance of the
control and multiplied by 100 as follow:

% of Cell Viability = Absorbance of Sample X 100
Absorbance of Control

Moreover, to detect the changes in the morphology of the HepG2 cell line along the
experiment conditions, we monitored it microscopically. The used microscope was the
inverted microscope (Olympus 1X20, USA) under 20x magnification power, where we
captured photos for different conditions of the cell line; normal control condition
(incubation with RPMI 1640 medium), oxidative stress condition (incubation with
different concentrations of H2O2) and oxidative stress condition with prior incubation
with TrxATII protein.
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12.

Kinetics of TrxATII
The Trx system as a whole is composed of thioredoxin (Trx), thioredoxin

reductase (TrxR), and NADPH that serves as a hydrogen donor. Trx is a small
monomeric protein

with

its

typical

active site motif (-Cys–XX–Cys-) that

catalyzes thiol-disulfide exchange. The oxidized inactive form of Trx (Trx-S2) is
reduced on the expenses of NADPH through the TrxR. Moreover, the reduced
active form of Trx (Trx-SH2) catalyzes the reduction of disulfides in oxidized
proteins as follow 1, 2:



Trx-S2 + NADPH + H+



Trx-SH2 + Protein – S2

TrxR

Trx-SH2 + NADP+
Trx-S2 + Protein – SH2

To obtain the kinetic parameters of Trx system, we have used the DTNB reduction assay.
We have calculated the kinetic parameters towards two substrates; TrxATII and DTNB.
For the TrxATII; 100mM phosphate buffer at pH 7.5, 2mM EDTA, 1mM DTNB (Cat.
No. 20735.02, Serva), TrxATII (0.2-12 µM), 0.1µM E.coli TrxR (Cat. No.TR-01, IMCO
Corporation Ltd AB) and 200 µM NADPH. For the DTNB; 100 mM phosphate buffer at
pH 7.5, 2mM EDTA, DTNB (0.01-1mM), TrxATII (4µM), 0.1µM E.coli TrxR, and 200
µM NADPH. The parameters were calculated from the increase in absorbance at 412 nm,
where one enzyme unit in the DTNB reduction assay was deﬁned as the NADPHdependent production of 2 µmol of 2-nitro-5- thiobenzoic acid per minute (Ɛ412 = 13.6
mM-1.cm-1) 82. We have applied Michaelis–Menten equation to calculate the Km (µM)
and Kcat (S-1), where the Km is the substrate concentration at which the reaction rate is
half of Vmax (maximum reaction velocity), while the Kcat (turnover number) measures
the number of substrate molecules turned over per enzyme molecule per second 82.
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Chapter 3: Results
1.

Retrieving TrxATII gene from metagenome of LCL
TrxATII gene was retrieved directly from the metagenome of the LCL via

performing PCR with the designed thioredoxin primers on 1x LCL. The PCR product
was loaded on 0.8% agarose gel electrophoresis. As shown in Figure 22, there is a clear,
thick and separated band for the TrxATII gene at its proper expected size; ~ 540 bp. To
perform the following experiments on TrxATII gene, we have excised the TrxATII band
from the agarose gel and purified it.

Lane 1

Lane 2

1000 bp
700 bp
500 bp
400 bp
300 bp

Figure 22: 0.8 % Agarose Gel Electrophoresis for TrxATII gene
Lane 1; Reference molecular weight ladder; Thermo Scientific GeneRuler 1 kb Plus DNA
Ladder (Cat. No. # SM1331). Lane 2 is the metagenome of the 1x LCL showing a clear
band for TrxATII gene at ~ 540 bp.
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2.

Recombinant TrxATII Clones (pGEM®-T Easy vector)
Successful cloning of TrxATII gene into the pGEM®-T Easy vector interrupts the

coding sequence of β-galactosidase enzyme. As shown in Figure 23, successful
recombinant clones of E. coli Top 10 are recognized by their white colored colonies on
the indicator plates [LB, Ampicillin (100μg/ml), IPTG (0.5mM) and X-Gal (80μg/ml)
agar plates], where twenty clones were picked up for gene sequencing. On the other
hand, unsuccessful cloning of TrxATII gene was represented by the blue colonies.

IPTG / X-Gal / Ampicillin / LB agar indicator plate

Figure 23: Recombinant TrxATII Clones of Top 10 E. coli
Showing recombinant white colonies comprising pGEM vector with thioredoxin insert on
indicator plates [LB, Ampicillin (100μg/ml), IPTG (0.5mM) and X-Gal (80μg/ml) agar
plates], while blue colonies represent the unsuccessful cloning of TrxATII gene.
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3.

TrxATII gene Sequencing

3.1

Plasmid Extraction (pGEM®-T Easy Vector)
To sequence the TrxATII gene, we extracted the pGEM®-T Easy plasmid from

the picked white colonies, where each picked colony sub-cultured in a separate falcon
tube containing LB broth/Ampicillin (100μg/ml) overnight at 37°C with shaking at ~ 200
rpm. For plasmid extraction, we have used the PureYield™ Plasmid Miniprep System
(Cat.No.A1223, Promega). As shown in Figure 24, the twenty plasmids were analyzed
on 0.8% agarose gel electrophoresis showing clear bands at the expected size ~ 3540 bp;
3000 bp for pGEM vector plus 540 bp for TrxATII insert.

A

20

1

4000 bp
3000 bp
2000 bp
1500 bp
1000 bp

Figure 24: 0.8 % Agarose Gel Electrophoresis for pGEM vector
comprising TrxATII gene
Lane A; Reference molecular weight ladder; Thermo Scientific GeneRuler 1 kb Plus
DNA Ladder (Cat. No. # SM1331). Lanes from 1 till 20 are showing extracted pGEM T
plasmids comprising TrxATII gene at ~ 3540 bp.
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For furthermore confirmation, PCR reaction was performed with the previously
mentioned conditions on the twenty extracted pGEM plasmids using thioredoxin primers
(Forward and Reverse) and analyzed on 0.8% agarose gel electrophoresis as shown in
Figure 25.

A

1

10

A

11

20

1500 bp
1000 bp
700 bp
500 bp

1500 bp
1000 bp
700 bp
500 bp

Figure 25: 0.8 % Agarose Gel Electrophoresis for TrxATII gene
Lane A; Reference molecular weight ladder; Thermo Scientific GeneRuler 1 kb Plus
DNA Ladder (Cat. No. # SM1331). Lanes from 1 till 20 are showing amplified TrxATII
gene from pGEM vector at its proper size ~ 540 bp.
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3.2

Sequence analysis of TrxATII
TrxATII sequence that has been generated from Applied Biosystems 3730xl DNA

Analyzer machine was BLASTed against non-redundant (nr) protein databases using
Basic Local Alignment Search Tool (BLASTP) provided by the National Center for
Biotechnology Information (NCBI). The protein sequence of TrxATII is shown in Figure
26.

Figure 26: Amino acid sequence of TrxATII Vs Prochlorococcus marinus Trx
The figure is showing the TrxATII sequence, where there are 25 amino acid difference
(highlighted in red) than the first hit (Prochlorococcus marinus Trx). Additionally, the
Trx active site (C72: C75) is highlighted in blue color.

Moreover, using ClustalW version 2.1, we have performed a multiple sequence alignment
of TrxATII with other members of the Trx super family: Prochlorococcus marinus,
Synechococcus sp, Cyanobium sp, Lyngbya sp., where the alignment showed the
conserved catalytic active site of Trx Super Family (Figure 27).
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Figure 27: Conserved Catalytic Active Site of Trx Super Family
Multiple sequence alignment of TrxATII with other members of the Trx super family:
Prochlorococcus marinus, Synechococcus sp, Cyanobium sp, Lyngbya sp. was performed
using ClustalW version 2.1. The alignment shows the conserved catalytic active site of
Trx Super Family, where they have two vicinal cysteines (highlighted in red) comprising
in between other two amino acids.
Additionally, a pairwise alignment for TrxATII against the first hit; Prochlorococcus
marinus Trx (accession number WP_002807427.1) was generated. Interestingly, the
alignment has shown 25 (14%) amino acids difference. Within the 25 amino acids
difference, we have noticed that there are 7 acidic residues in TrxATII versus 2 residues
in Trx Prochlorococcus marinus and 1 basic residue in TrxATII versus 5 residues in
Prochlorococcus marinus (Figure 28).
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Catalytic Active Site

Figure 28: Alignment of TrxATII with best hit
Alignment with the best hit thioredoxin protein from Prochlorococcus marinus showed
maximum identity 86%, the highest among all

3.3

3D modeling of Trx (ATII versus Prochlorococcus marinus)
The 3D modeling of Trx motif has shown the catalytic active site (– Cys72 –

Glu73 – Val74 – Cys75–) (Figure 29).
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Figure 29: 3D modeling of Trx (ATII versus Prochlorococcus marinus)
The 3D modeling is showing the Trx active site (– Cys72 – Glu73 – Val74 – Cys75–) in
both ATII and Prochlorococcus marinus. Additionally, among the 25 amino acids
difference between them, there are 7 acidic residues in TrxATII versus 2 residues in Trx
Prochlorococcus marinus and 1 basic residue in TrxATII versus 5 residues in
Prochlorococcus marinus.
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3.4

Construction of Phylogenetic tree
The generated phylogenetic tree (Figure 30) showed that TrxATII sequence is

highly similar to different strains of Prochlorococcus marinus Trx. Table 3 lists the
sequence identifiers used to compute the tree. The TrxATII is clustered in the clade of
different strains of Prochlorococcus marinus Trx, which is evidence for the various stress
conditions at the LCL that requires the TrxATII. Moreover, TrxATII modified to
accommodate the harsh conditions; thermohalophilicity at the sea bed.

Figure 30: TrxATII Phylogenetic tree
A Phylogenetic tree for the TrxATII was constructed using CLUSTALW version 2.1 77,78
. The generated tree is Neighbour-joining tree including the sequences most similar to the
TrxATII sequence.
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Table 3: Organisms used in Phylogenetic tree

Organism

Accession Numbers

Synechococcus sp. CC9605

ref|YP_380605.1|

Synechococcus sp. WH 8102

ref|NP_896375.1|

Prochlorococcus marinus str. MIT 9313

ref|NP_895653.1|

Synechococcus sp. WH 7805

ref|WP_006042318.1|

Cyanobium sp. PCC 7001

ref|WP_006911410.1|

Raphidiopsis brookii

ref|WP_009341404.1|

Cylindrospermopsis raciborskii

ref|WP_006277703.1|

Fischerella muscicola

ref|WP_016866661.1|

Richelia intracellularis

ref|WP_008234229.1|

Oscillatoriales cyanobacterium JSC-12

ref|WP_009556771.1|

Gloeobacter kilaueensis JS1

ref|YP_008713253.1|

Prochlorococcus marinus subsp. pastoris str.

ref|NP_892361.1|

CCMP1986
Prochlorococcus marinus str. MIT 9515

ref|YP_001010591.1|

Prochlorococcus marinus

ref|WP_002807427.1|

Prochlorococcus marinus str. MIT 9301

ref|YP_001090489.1|

Prochlorococcus marinus str. MIT 9312

ref|YP_396741.1|

Prochlorococcus marinus subsp. marinus str.

ref|NP_874666.1|

CCMP1375
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4.

Transformed TrxATII clones (pET SUMO® Vector)
Successful cloning of TrxATII gene into the pET SUMO® expression vector,

allows the growth of the white colonies of the transformed BL21 (DE3) E. coli cells on
their indicator plates [LB / Kanamycin (50μg/ml)] as shown in Figure 31.

Kanamycin / LB agar indicator plate

Figure 31: Transformant TrxATII Clones of BL21 (DE3) E. coli
The transformed white colonies are spread on the whole plate, comprising pET SUMO
vector with TrxATII insert on indicator plates [LB / Kanamycin (50μg/ml)].
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4.1

Analyzing Transformants
To analyze the transformed BL21 (DE3) E. coli, PCR reaction was performed on

five clones, where each picked colony sub-cultured in a separate falcon tube containing
LB broth/kanamycin (50μg/ml) overnight at 37°C with shaking at ~ 200 rpm. The PCR
conditions performed as previously mentioned using the thioredoxin primers (Forward
and Reverse) and analyzed on 0.8% agarose gel electrophoresis. As shown in Figure 32,
the amplified TrxATII gene band appeared clearly at its proper size ~ 540 bp. in all the
picked colonies.
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1500 bp
1000 bp
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500 bp
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Figure 32: 0.8 % Agarose Gel Electrophoresis for TrxATII gene in pET
SUMO® Vector
Lane A; Reference molecular weight ladder; Thermo Scientific GeneRuler 1 kb Plus
DNA Ladder (Cat. No. # SM1331). Lanes from 1 till 5 are showing amplified from
TrxATII gene from pET SUMO vector at its proper size ~ 540 bp.
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5.

IPTG-inducible Expression of TrxATII
During the inducible expression of the recombinant TrxATII protein using

isopropyl β-D-thiogalactoside (IPTG), 4 samples were collected to be analyzed on the
SDS-PAGE electrophoresis. Moreover, the 4 samples were as follow: E. coli expressed
proteins before IPTG induction phase, E. coli expressed proteins after IPTG induction
phase, non-induced E. coli pellets and induced E. coli pellets. As shown in Figure 33,
both the induced pellets and induced proteins showed

more intensified bands for

TrxATII protein at its proper size ~ 12 KDa rather than that of the non-induced pellets
and proteins.

Figure 33: SDS-PAGE Electrophoresis for induced and non-induced TrxATII
Lane A and B show ProSieve®Color Protein Markers (Cat. No.50550, Lonza).
Lane 1 shows E. coli non-induced TrxATII overnight.
Lane 2 shows E. coli induced TrxATII overnight.
Lane 3 shows E. coli induced TrxATII over 2 hours.
Lane 4 shows E. coli non-induced pellets.
Lane 5 shows E. coli induced pellets over 2 hours.
Lane 6 shows E. coli induced pellets overnight.
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6.

Purified TrxATII fractions
Purification of recombinant TrxATII protein was done against metal-chelating

resin (Ni-NTA agarose resin, Cat.No.R901-15, Invitrogen™), where the Ni-NTA resin
has high affinity and selectivity for 6xHis-tagged recombinant TrxATII protein. Different

samples of purified TrxATII were taken for SDS-PAGE electrophoresis analysis. As
shown in Figure 34, all E. coli proteins were washed out, while different fractions of
the recombinant TrxATII protein was eluted and purified.

Figure 34: SDS-PAGE Electrophoresis for purified fractions of TrxATII
Lane A shows ProSieve®Color Protein Markers (Cat. No.50550, Lonza), while Lanes
from 1 to 9 show purified fractions of TrxATII at ~ 16 KDa.
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7.

Quantification of TrxATII fractions
After dialysis, we quantified the concentration of TrxATII protein in each eluted

fraction using the Thermo Scientific Pierce BCA Protein Assay (Cat.No.23225, Thermo
SCIENTIFIC). As shown in Figure 35, we have got different concentrations for TrxATII
fractions from different induction batches, where the highest concentration was 1303
μl/ml.

BCA Protein Assay
2.5

2
y = 0.0011x + 0.0534
R² = 0.9916
1.5
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0.5
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Figure 35: Quantification of TrxATII concentration
Using the Thermo Scientific Pierce BCA Protein Assay kit (Cat.No.23225, Thermo
SCIENTIFIC), different concentrations for TrxATII fractions from different induction
batches have been quantified after plotting the standard curve of BSA; 1303ug/ml, 216
ug/ml, 168 ug/ml and 125 ug/ml.
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8.

Cell Culture and MTT Assay
The oxidative stress conditions applied on the cell culture of the cancerous HepG2

cell line after pretreatment with different concentrations of the antioxidant TrxATII
protein was maintained to assess the antioxidant role of TrxATII via MTT assay. After,
the HepG2 cell line reached a confluence stage (after 24 hours incubation), we induced
oxidative stress via different concentrations of H2O2 (100, 200, 800 and 1600 μM) for 4
hours. Additionally, we induced oxidative stress condition with the same concentrations
of H2O2, but after the prior exposure to different TrxATII concentrations (1, 2.5 and 5
μM) for 1 hour. Morphologically under the inverted microscope and 20X magnification
power, HepG2 cells show full attachment after 24 hours incubation with RPMI 1640
media as shown in Figure 36 A, while the cells detached and became more rounded upon
incubation with different concentration of H2O2 (100, 200, 800 and 1600 μM) for 4 hours
as shown in Figure 36 B1, C1, D1 and E1. Moreover, the pre-incubation of the HepG2
cells with TrxATII protein (5 μM) for 1 hour prior oxidative stress induction, shows less
detachment with much better survival rather than the oxidative stress conditions only as
shown in Figure 36 B2, C2, D2 and E2. Although, we have examined different
concentrations of TrxATII protein (1, 2.5, 5μM), the optimum antioxidant concentration
that reduced the oxidative stress and showed better cell survival percentage was the 5
μM. Furthermore, in the MTT assay, the exposure of the HepG2 cells to 5μM TrxATII
for 1 hour prior the oxidative stress exposure for 4 hours showed survival advantage as
shown in Figure 37. At 100μM, 200μM, 800μM and 1600μM H2O2, the survival were
87%, 64%, 8% and 3.5% respectively. On the other hand, the pretreatment with 5μM
TrxATII improved the survival to 89%, 69%, 10.7% and 8.8 respectively (Figure 37).
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D1

D2
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Figure 36: Morphology of HepG2 cells upon induction of oxidative stress conditions using
H2O2 (100μM, 200 μM, 800 μM and 1600 μM) in presence and absence of
5μM TrxATII under 20x magnification power.
(A ) Confluent sheath of HepG2 cells after 24 hours incubation in RPMI 1640 media.
(B1) HepG2 cells after 4 hours incubation with 100μM H2O2
(B2) HepG2 cells after 1 hour exposure to 5μM TrxATII then 4 hours incubation with 100μM H2O2
(C1) HepG2 cells after 4 hours incubation with 200μM H2O2
(C2) HepG2 cells after 1 hour exposure to 5μM TrxATII then 4 hours incubation with 200μM H2O2
(D1) HepG2 cells after 4 hours incubation with 800μM H2O2
(D2) HepG2 cells after 1 hour exposure to 5μM TrxATII then 4 hours incubation with 800μM H2O2
(E1) HepG2 cells after 4 hours incubation with 1600μM H2O2
(E2) HepG2 cells after 1 hour exposure to5μM TrxATII then 4 hours incubation with 1600μM H2O2
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Effect of 5uM Trx in reducing Oxidative Stress induced on HepG2
120

p-value 1.506 E-12

Viability %
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5uM Trx
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H2O2 4 hrs incubation

20
0

Control 100uM 200uM 800uM 1600uM
H2O2 H2O2 H2O2 H2O2

Figure 37: Effect of 5uM TrxATII in reducing Oxidative Stress induced
on HepG2
Cell survival of HepG2 cells after exposure to oxidative stress conditions for 4 hrs, as per
MTT assay. Left to right: (1) Control untreated HepG2 cells, (2) 100uM H2O2, (3)
200uM H2O2, (4) 800uM H2O2, and (5) 1600uM H2O2. The presented data are mean of
three independent experiments, where each concentration is mean of three. The p-value =
1.506 E-12 and the p-value range < 0.001 were computed by ANOVA R© version 2.14.1,
a statistical analysis program.
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9.

Redox Activity and Characterization of TrxATII

9.1

Redox Activity at room temperature
To examine the redox activity of TrxATII, we have performed the insulin

reduction assay at room temperature as described in the materials and methods. As shown
in Figure 38, the absorbance increased rapidly at 650 nm, demonstrating the successful
reduction of insulin via disulfide bond exchange with TrxATII.

Figure 38: Redox activity of TrxATII at room temperatures
The redox activity of TrxATII was assayed at room temperature via insulin reduction
assay, where the aggregation of insulin was measured spectrophotomerically at 650 nm. It
is clear that the absorbance increased rapidly until the insulin consumed, then formed a
plateau.
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9.2

Thermostability
The effect of increasing temperature on the activity of TrxATII was assayed, where

Trx was incubated at range of temperatures (25oC to 80oC) for 10 minutes after which the
residual activity was assessed by the insulin reduction assay, where the aggregation of
insulin was measured spectrophotomerically at 650 nm. As shown in Figure 39, the
residual activity of TrxATII was 100 %, 100 %, 97.23 %, 90.59 %, 65.57 %, and 10.25%
at 25 ᵒC, 37 ᵒC, 50 ᵒC, 60 ᵒC, 70 ᵒC, and 80 ᵒC respectively.
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Figure 39: Redox activity of TrxATII at different temperatures
(Thermostability)
After incubating thioredoxin at different temperatures (25 ᵒC – 80 ᵒC), the residual
activity of thioredoxin was assayed via insulin reduction assay, where the aggregation of
insulin was measured spectrophotomerically at 650 nm. It is clear that the residual
activity of thioredoxin was 100 %, 100 %, 97.23 %, 90.59 %, 65.57 %, and 10.25 % at 25
ᵒC, 37 ᵒC, 50 ᵒC, 60 ᵒC, 70 ᵒC, and 80 ᵒC respectively.

72

9.3

Halophilicity
The effect of NaCl concentration on the redox activity of TrxATII was assayed at

different molar concentrations of NaCl (0.5M – 4M) using the insulin reduction assay. As
Shown in Figure 40, the redox activity of TrxATII increased gradually from 6.09
uM/min/mg at 0.5M NaCl to reach its maximum (30.15 uM/min/mg) at 2.5M NaCl, and
then shows gradual decrease in redox activity till the lowest activity (0.54 uM/min/mg) at

Activity (µmole/min/mg)

4M NaCl.
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Figure 40: Redox activity of TrxATII at different NaCl molar
concentrations (Halophilicity)
The effect of NaCl concentration on the redox activity of TrxATII was assayed at
concentrations 0.5M – 4M using the insulin reduction assay. The redox activity of
TrxATII increased gradually from 6.09 uM/min/mg at 0.5M NaCl to reach its
maximum (30.15 uM/min/mg) at 2.5M NaCl, and then shows gradual decrease in
redox activity till the lowest activity (0.54 uM/min/mg) at 4M NaCl.
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10.

Kinetic parameters of TrxATII
The kinetic parameters were determined (shown in Table 4) as described in

Materials and Methods. The Km and Kcat for TrxATII was 1.23 µM and 25.74 S-1
respectively, while the Km and Kcat for DTNB was 95.72 µM and 15.34 S-1 respectively.
By comparing our kinetic parameters versus other thermostable Trx system; aerobic
hyperthermophilic archaeon Aeropyrum pernix K1, the Km and Kcat for Trx was 12.3
µM and 63.2 S-1 respectively, while the Km and Kcat for DTNB was 172.4 µM and 9 S-1
respectively83. Thus, it is clear that the number of Aeropyrum pernix Trx molecules
turned over per enzyme molecule per second (63.2 S-1) is more than double of that of
TrxATII (25.74 S-1). Basically, the reason behind that is the source of TrxR used in our
DTNB assay, where it is form E.coli source (Cat. No.TR-01, IMCO Corporation Ltd AB)
and not from the same environment of TrxATII; Atlantis II brine pool, which could lead
to a kind of incompatibility.

Table 4: Kinetics of TrxATII using DTNB assay
Assay

Substrate

Km (µM)

Kcat (S-1)

DTNB

TrxATII
(0.2-12 µM)

1.23

25.74

DTNB

DTNB
(0.01-1 mM)

95.72

15.34

The kinetic parameters were determined as described in Materials and Methods.
The Km value for TrxATII was determined at 0.2 – 12 µM TrxATII and 1 mM
DTNB. Moreover, the Km value for DTNB was determined at 0.01 – 1 mM
DTNB and 4 µM TrxATII.
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Chapter 4: Discussion
In this thesis work, we have characterized a novel thermohalophilic antioxidant
TrxATII from the metagenome of the Lower Convective Layer (LCL) of the
Atlantis II Deep brine pool in the Red Sea. Basically, the Atlantis II Deep is the
biggest discovered brine pool in the Red Sea until now, about 6 x 13 Km

11

. The

environment of the LCL has unusual blend of tough conditions; extremely high
temperature that reaches 68.2°C, salinity of about 26%, which is 7.5 folds more
than that of other seas and its pH value is 5.3

5, 10.

Furthermore, the LCL of

Atlantis II Deep is almost oxygen depleted environment (anoxic) and highly
enriched with sulfides of iron, zinc, copper and other heavy metals, in addition
to high value metals as silver, cobalt and gold

9, 10, 11.

That is why; it is very

attractive spot to understand the structural and functional modifications of
enzymes and proteins that have been adapted in sake of survival of the microbial
communities in these harsh abiotic conditions, in addition to the expectation to
discover novel genes, proteins and metabolic pathways that can be conveniently
applied in the industry of biotechnology or pharmaceuticals. In this study, we
have characterized TrxATII. To the best of our knowledge, this is first attempt to
mine for thioredoxin protein from the Atlantis II Deep.
TrxATII gene was retrieved directly from the metagenome of the LCL. For
further characterization of TrxATII, we have induced high quantities via sub-cloning into
a high copy number vector (pGEM®-T Easy), where we have selected the recombinant
clones (White/Blue Screening) to be further analyzed and sequenced to identify the
TrxATII. Futhermore, TrxATII similarity search against NCBI non-redundant protein
database was done using the BLASTP (2.2.29)98 (NCBI). The first best hit was
thioredoxin protein from Prochlorococcus marinus [str. MIT 9202] (thioredoxin family
protein) (Accession: WP_002807427.1) with maximum identity 86%, similarity up to
92% and coverage 98% of the query length, (Figure 40). Other hits were from other
strains of Prochlorococcus marinus; MIT 9215, MIT 301, MIT 312, MIT 515, and AS
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9601 as well as other species; Synechoccus sp (identity 44%), Richelia sp (identity 37%),
Oscillatoriales sp. (identity 34%), Lyngbya sp. (identity 34%), Cylindrospermopsis sp
(identity 33%),
Moreover, TrxATII protein’s sequence showed the thioredoxin motif; two vicinal
Cysteines comprising two amino acids in-between (CEVC), with the maximum identity
of 86% with Prochlorococcus marinus (first hit). Interestingly, the TrxATII amino acid
sequence differs from the first hit (Trx of Prochlorococcus marinus) by 14 % represented
by 25 amino acids that changed the thermo-halophilicity properties of the protein, where
the TrxATII has extra 7 acidic residues. Subsequently, upon performing activity assay of
TrxATII, it showed redox activity at wide range of temperatures (25oC to 80oC) and at
different molar concentrations of NaCl (0.5 – 4 M). In conclusion, it is clear that there is
various stress conditions at the LCL of ATII that requires the presence of Trx. Moreover,
TrxATII has been modified to accommodate the unique harsh condition at the LCL of
Atlantis II brine pool at Red Sea via its thermo-halophilic nature.
This work supports the potentiality of the metagenomic approaches in identifying
novel proteins with unique characteristics and potential applications from communities
inhabiting extreme environments.
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Chapter 5: Conclusion and Future Prospects
In conclusion, we have identified a novel TrxATII protein from the Atlantis II
brine pool in the Red Sea. Sequence analysis of TrxATII revealed its difference from
other thioredoxins, which has high impact on its thermophilic and halophilic
characteristics. We are recommending further characterization of TrxRATII to understand
the whole thioredoxin system at the Atlantis II brine pool.

Moreover, there is a room for research that could be conducted to complement this study.
Basically, different points should be addressed;
1-

Will the combination of the TrxRATII with the TrxATII improve the antioxidant

profile of the whole Trx system?
2-

During the in vitro assay of the TrxATII on the HepG2 cells, we introduced

TrxATII to the cell culture. Does the cloning of both TrxATII gene and TrxRATII within
the genome of the cell line improve the antioxidation profile (to implement the whole Trx
system from ATII)?
3-

If we examined another cell line, will the antioxidation activity of TrxATII be

altered?

To wrap up, using recombinant TrxATII could have a wide range of potential therapeutic
applications in different oxidative stress conditions as in cancer, which should be
examined in various animal models as a potential antioxidant candidate.
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